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Abstract 
 
Natural products continue to be a valuable source of compounds in research involving 
chemical ecology and drug discovery. Secondary metabolites are biosynthesized to 
benefit the host organism in its environment (feeding deterrence from predators, 
antibiotic properties to avoid infection, etc.) but these compounds also serve as useful 
scaffolds in drug discovery applications. The research herein describes both aspects of 
these two branches of natural products chemistry. The Antarctic sponge Dendrilla 
membranosa produces diterpenes, of which membranolide A, deters feeding of the 
predatory amphipod Gondogeneia antarctica. A metabolomic study of several sponges 
was undertaken to determine environmental factors that govern the metabolism of D. 
membranosa. Habitat specificity, above or below the algal canopy, was a significant 
factor for the chemical clustering of sponges as well as the abundance of potential 
amphipod predators that are prevalent within the canopy.  Another D. membranosa 
diterpene, aplysulphurin, undergoes degradation upon methanolic treatment to form the 
methoxy membranolides B-H. An investigation of these artifacts reveals potent activity 
against the leishmaniasis-causing parasite Leishmania donovani. Microorganisms also 
generate a significant number of bioactive natural products. Biotic and abiotic culture 
stressors such as co-culturing and epigenetic modification, respectively, will be explored 
to turn on cryptic biosynthetic pathways. These techniques are shown to produce unique 
secondary metabolites from cultures and further reinforce the one strain many 
compounds approach to the versatile and formidable microbial domain. 
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Chapter 1. Evolution of Natural Products 
 
1.1 How It All Began (The Beginning?) 
The origin of life on Earth is not fully understood, but it is widely accepted that organisms 
started simplistic and evolved into larger, more complex beings. The Darwinian concept states 
that small, beneficial mutations are vital to the evolution and survival of a species.1 Over 
millions of years the more robust species have adapted and optimized their lifestyle to live in 
their environment. One such adaptation is the biosynthesis of secondary metabolites, compounds 
which have no primary role in the life cycle but can attract or repel other organisms to improve 
survival of the producer.2 The term secondary metabolite and natural product are used 
synonymously, but “secondary” refers to processes not involved in primary growth (i.e. lipids, 
amino acids, carbohydrates and proteins). These primary metabolites and their functions are 
universal throughout living organisms whereas secondary metabolites are predominantly species-
specific and influenced by their surroundings. Natural products chemists are tasked with 
elucidation of these metabolites, understanding their role in the natural environment, and to see if 
they can be beneficially exploited by humans.  
 
1.2 Chemical Ecology- Chemical Cues in the Environment 
In nature there are countless interactions that occur between competing and cooperative 
organisms that are mediated by secondary metabolites, creating a chemically complex 
environment. These types of interactions govern the realm of chemical ecology, and for the sake 
of this review only defensive constituents will be considered. Invertebrates, as opposed to 
!! 2!
vertebrates which utilize their mobility, nervous and immune systems for defense,3 are 
considerable producers of secondary metabolites to deter predation, prevent fouling and 
overgrowth, and provide protection from UV radiation.4 Some of the earliest chemical studies 
identified the cardiac glycosides sequestered by the grasshopper5 and monarch butterfly6,7 from 
their plant food source. Plants from the terrestrial realm have been well studied with an estimated 
200,000 secondary metabolites characterized to date.8 Since we are land-dwellers, terrestrial 
sources of natural products were first to be exploited but research always expands into new 
environments, like the underexplored seas. 
 
1.2.1 Marine Chemical Ecology 
With over 70% of Earth’s surface covered by water, the oceans contain a wealth of biodiversity 
that has yet to be investigated.9 Marine natural products research was not practical until the 
advent of SCUBA in the 1950’s; this sparked a revolution started by the late Paul Scheuer and 
John Faulkner. Sessile benthic invertebrates, often without physical defenses such as a shell or 
tough, spiny skin, instead turn to chemical defenses to protect themselves.4 Sponge defensive 
metabolites have been well-documented10-12 but there are numerous reports of secondary 
metabolites with ecological value in algae,13-22 cnidarians,23-26 ascidians,27-29 mollusks,28,30-37 and 
enchinoderms.38-41 Recent emphasis has been to discover new natural products from extreme 
environments like the deep sea42 and the cold waters of Antarctica.43,44 
 
1.2.2 Antarctic Marine Natural Products 
Antarctica separated from Gondwanaland in the Mesozoic Era, about 150 million years ago, 
rendering an isolated ecosystem.45 The coldest continent on Earth is surrounded by the Southern 
!! 3!
Ocean, covers 34.8 million km2 and is mostly covered by ice in the winter with significant near-
shore thawing during summer.46 Below the surface a vast continental shelf (average depth 450 
m) drops steeply to the ocean floor with the walls harboring immense invertebrate life. The 
Antarctic Circumpolar Current (ACC) continuously circles the continent unimpeded by land 
mass and circulates nutrients and heat to the continental shelf. The western Antarctic Peninsula 
(WAP) juts 1500 km into the Southern Ocean and is heavily influenced by the ACC. These 
conditions foster biodiversity with over 4100 described Antarctic benthic species described to 
date47 despite seasonal variations and shallow-water ice scouring posing significant stressors to 
these organisms.48 The abundant nutrients and sunlight are ideal for primary producers such as 
phytoplankton and macroalgae on the WAP.49 The dense macroalgal canopy provides 
mesograzers a habitat for shelter and reproduction as well as a viable food source.50-53 Below the 
phototropic zone secondary producers such as sponges, corals, bryozoans, hydroids, and 
ascidians are found.54 In addition, marine-based macroinvertebrate predators are prevalent 
throughout the benthos including crustacean mesograzers, nemerteans, sea stars, sea urchins, sea 
cucumbers, brittle stars, and fish.54-58 This competition for space on the Antarctic benthos 
promotes a highly diverse chemically defended community and prey-predator interactions 
between organisms result in unique secondary metabolites used in “chemical warfare.” 
 
A review in 2008 approximated 300 secondary metabolites isolated from Antarctic organisms59 
but recent searches on Scifinder and MarinLit databases reveal over 600 identified metabolites. 
These numbers indicate that further resources have been employed to explore this inimitable 
habitat; and the reward has been a plethora of new natural products with a wide-array of 
ecological bioactivity. Sponges have been well studied as certain parts of the Antarctic benthos 
!! 4!
are covered up to 50% with these sessile invertebrates60,61 and numerous studies have focused on 
feeding deterrence against common Antarctic predators.62-71 Further details of the sponge-
associated feeding deterrents will be addressed in the next chapter.  
 
The shallow waters of the Southern Ocean are dominated by macroalgae. A study conducted by 
Amsler et al.72 tested the palatability of 35 subtidal algae found that the majority were chemically 
defended against common herbivores including the sea star, fish, and amphipod predators. The 
red alga Plocamium cartilagineum produces polyhalogenated monoterpenes (1.1 and 1.2) and 
furoplocamioid C (1.3) with significant toxicity towards aphid predators.73 Another study 
involving P. cartilagineum isolated further terpenes epi-plocameme D (1.4) and menzoquinone 
(1.5) with deterrence toward the sea star Odontaster validus while anverene (1.6) deterred 
feeding of the omnivorous amphipod Gondogeneia antarctica.74  
 
Cl
Cl Cl Cl Br
Cl
Cl
Br Br
Cl
O
OH
Cl
Br
Br
Cl
1.1 1.2 1.3 furoplocamioid C
Cl Cl
Cl
O
O HO
O
Br
Br
Cl
Cl
1.4 epi-plocameme D
1.5 menzoquinone
1.6 anverene
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Another promising group of sessile organisms is the cnidarians with soft corals being the most 
chemically documented. A suite of water-borne sterols released from Alcyonium paessleri 
produced avoidance behavior from three echinoderms and the nemertean Parborlasia corrugatus 
in Y-maze experiments, and also sea star tube-foot retraction of O. validus.75 A sesquiterpene 
isolated from Ainigmaptilon antarcticus, ainigmaptilone A (1.7), had a variety of ecological 
activity including deterrence toward O. validus and antibiotic activity against a panel of 
sympatric Antarctic bacteria.76 The gorgonian Dasystenella acanthina produces 
furanoeudesmane (1.8) and isofuranodiene (1.9) with significant feeding deterrence towards 
fish.77 
 
Mollusks represent an unusual class of animals on the Antarctic benthos that are sluggishly 
mobile and often lack physical defense, such as nudibranchs which rely on chemical defenses to 
moderate predation. It has been postulated that nudibranchs obtain their chemical defense 
through dietary means, as was the case of chimyl alcohol from Tritoniella belli,78 however 
further investigations found that Austrodoris kerguelenensis produces its defensive metabolites 
through de novo biosynthesis.36,79 Hodgsonal (1.10) found in Bathydoris hodgsoni was theorized 
to be produced de novo though it has not been confirmed.36,80 The biosynthesis of diterpene 
glyceride esters has been confirmed in A. kerguelenensis though the metabolites produced vary 
between individual populations.81-83 The compounds 1.11- 1.12 isolated by Iken et al.79 deter 
O
OH
H
O O
H
1.7 ainigmaptilone A 1.8 furanoeudesmane 1.9 isofuranodiene
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feeding by O. validus, a significant nudibranch predator, thus confirming their ecological role. 
Further diterpenes (1.13- 1.17)81,82,84 have been isolated from A. kerguelenensis as well as 
palmadorins D-S83 which all share a similar scaffold with the known feeding deterrents. A 
pelagic mollusk, the shell-less pteropod Clione antarctica, produces pteroenone (1.18) to protect 
itself, and often an associated amphipod, from fish predation. 
!
Tunicates from Antarctica are understudied although their secondary metabolites have shown 
promise in both ecological and therapeutic bioassays. The meridianins (1.19- 1.25) produced by 
Aplidium spp.85,86 and Synoicum sp.87 have feeding deterrent properties against O. validus when 
assayed as mixtures.86 Palmerolide A (1.26) was isolated from a Synoicum adareanum tunicate, 
CHO
H
AcO
OAc
1.11 R1=  H, R2=  Ac
1.12 R1=  Ac, R2=  H
O
O
OH
R2
R1
AcO
1.13 austrodorin A; R1=  OAc, R2= H
1.14 austrodorin B; R1=  H, R2= OAc
1.10 hodgsonal
O
O
H
1.15 palmadorin A: R= H
1.16 palmadorin B: R= Ac
O
O
H
OH
OHOH
OH
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1.17 palmadorin C
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O OH
1.18 pteroenone
O
O
OR2
OR1
!! 7!
and while no ecological activity has been proposed for this compound, it does possess potent and 
selective activity against melanoma.88 This finding demonstrates that Antarctic natural products 
hold promise as starting points in drug discovery applications. 
 
 
1.3 Natural Product Drug Discovery 
Natural products have been used to treat a variety of ailments in many ancient civilizations.89 In 
modern times, however, drug discovery programs have shifted towards synthetics avoiding the 
chemical complexities (chirality, flexibility etc.) as well as the issue of supply. But there is no 
denying the importance of natural products as more than 50% of newly approved drugs (from 
N
H
N
N
H2N
R1
R2
R3
1.19 meridianin A: R1= OH, R2= H, R3= H, R4= H
1.20 meridianin B: R1= OH, R2= H, R3= Br, R4= H
1.21 meridianin C: R1= H, R2= Br, R3= H, R4= H
1.22 meridianin D: R1= H, R2= H, R3= Br, R4= H
1.23 meridianin E: R1= OH, R2= H, R3= H, R4= Br
1.24 meridianin F: R1= H, R2= Br, R3= Br, R4= H
1.25 meridianin G: R1= H, R2= H, R3= H, R4= H
R4
H
N
O
O
O
OH
HO
O
O
NH2
1.26 palmerolide A
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1981- 2010) stem from natural products or their derivatives.90 Both the land, and more recently, 
the sea have been explored for secondary metabolites culminating in a wealth of bioactivity 
against many therapeutic targets and disease states. 
 
1.3.1 Bioactive Natural Products 
Plants and botanical extracts derived from them have been used for thousands of years to treat 
ailments in the form of tinctures, teas, powders and other formulations.91 One of the early 
pharmaceutical successes came from acetylsalicylic acid (1.27), or aspirin, eventually developed 
by Bayer.92 Initially salicin was extracted from the bark of willow trees to treat inflammation, 
however, this compound caused stomach irritation. To combat this, an acetylated derivative 
(1.27) was developed. Aspirin generated $639 million in global sales in 2013.93 Despite the 
stigma that surrounds Cannabis spp. use, tetrahydrocannabinol (1.28) and cannabidiol (1.29) are 
sold as a mixture, under the name Sativex®, and have been recently shown to have promising 
analgesic properties94 and efficacy against multiple sclerosis.95 Other notable examples of plant-
derived medicines include morphine (1.30) for pain relief, the antimalarial artemisinin (1.31), 
and the microtubule stabilizer paclitaxel (1.32). The macro-environment, encompassing the scale 
of what we can see with the unaided eye, has provided countless natural product discoveries, but 
vast biodiversity lies in the microbial realm in the form of chemically rich fungi and bacteria.  
!! 9!
 
Microorganisms represent a significant untapped resource in the search for new natural products 
with only an estimated 1% of microbes characterized.96,97 From a supply standpoint, microbes 
have the advantage to be strictly regulated in laboratory-controlled conditions and are a 
renewable resource of natural products. Over 22500 bioactive microbial natural products have 
been documented comprising actinomycete bacteria (45% of the total), fungi (37%), and 
unicellular bacteria (17%).98 Microbes have diverse enzymology to biosynthesize structurally 
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diverse natural products with a wide range of biological activity particularly against cancer and 
infectious diseases.99 It can be hypothesized that microorganisms have evolved over time to 
produce secondary metabolites with antimicrobial properties. This “natural selection” can 
obviously be advantageous as microbes inhabit nearly every niche on the planet, and chemically 
defended species have increased their survivability in a complex and competitive environment. 
One of the hallmark discoveries in modern medicine arrived with penicillin (1.33) isolated from 
a Penicillium notatum fungus by Sir Alexander Fleming.100 This ushered in a new frontier for 
drug discovery and initiated the antibiotic area, many of which are microbial-derived and still 
being used today. To name just a few of these antibiotics, erythromycin (1.34) was isolated from 
a soil-derived Streptomyces actinobacteria,101 the broad-spectrum tetracycline (1.35) was also 
isolated from a Streptomyces sp.,102 and the newly discovered teixobactin (1.36) from an 
“unculturable” bacteria has a promising, novel mechanism of action against bacterial cell wall 
synthesis.103   
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Besides the strong market value of microbial-derived antibiotics, there are several other notable 
examples of approved treatments. The most profitable class of drugs, the cholesterol-lowering 
statins, are synthetic analogues of lovastatin (1.37) from a soil Aspergillus terreus fungus.104 For 
the treatment of leishmaniasis, a neglected tropical disease spread by sand flies, amphotericin B 
(1.38) is commonly prescribed.105 Amphotericin and its analogues were initially developed for 
their antibiotic properties and later for more broad-spectrum uses, are produced by a 
Streptomyces nodosus bacterium isolated from South American soil.106 The marine environment 
and its microbiota boast significant contributions to the field of anti-cancer research. Trabectedin 
(1.39), from the tunicate Ecteinascidia turbinata, has been approved for the treatment of soft 
tissue sarcoma in Europe and Asia under the trade name Yondelis®.107 Clinical trials involving 
bryostatin 1 (1.40), a polyketide discovered in the bryozoan Burgula neritina and found to target 
protein kinase C, have failed for cancer treatment, but phase II clinical trials have begun for the 
treatment of Alzheimer’s disease.108,109 A new obligate marine bacterium Salinosporamide 
tropica produces salinosporamide A (1.41), a proteasome inhibitor currently in phase I clinical 
trials.110 Compounds 1.39 and 1.40 were attributed to symbiotic microbial production even 
though they were originally isolated from their host organism.111,112 The evolution of genomic 
research has ushered a better understanding of microbial symbionts, their role with the host, and 
the production of bioactive compounds and their analogues. New isolation techniques have been 
explored to isolate these symbiotic microorganisms and culture them in the lab113,114 as well as 
varying culture techniques to elicit the production of new natural products.115,116 
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1.4 Research Objectives 
The research reported herein explores the relatively untouched environments of the Antarctic 
benthos and endosymbiotic marine microorganisms in the hunt for new natural products. The 
defensive metabolites of the Antarctic sponge Dendrilla membranosa were investigated to 
unearth their distribution with habitat and how predation influences their chemical clustering. In 
addition, the secondary metabolites of D. membranosa have activity against the leishmaniasis-
causing parasite Leishmania donovani, and methoxy-bearing membranolide analogues display 
even more potency. Marine microorganisms isolated from the temperate regions surrounding 
Florida were screened for bioactivity against infectious diseases. Culture alterations including 
co-culturing and epigenetic modification were investigated to increase secondary metabolite 
production. 
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Chapter 2. Ecological and Leishmanial Efficacies of Diterpenes from Dendrilla  
 
membranosa 
 
2.1 Ecological Study of D. membranosa 
2.1.1 Western Antarctic Peninsula (WAP) Habitat 
The waters surrounding the WAP support a 
diverse community dominated by competitive 
ecological interactions1 sustained by cold, 
nutrient rich waters of the ACC.2-4 The 
infralittoral zone (< 25 m depth, Figure 2.1) 
supports a dense forest of macroalgae with high 
concentrations of mesograzers that interact with 
algae by means of refuge, chemical defense, and 
other ecological cues.5 Below 25 m lies the 
circalittoral zone, a sponge-rich benthic 
community under biological mediation6-10 also 
supporting chemically rich species diversity.11,12  
 
The WAP lacks significant population of fish that prey on sessile invertebrates and algae, but 
amphipod mesograzers can be noteworthy consumers while reaching densities of 308000 m-2 in 
near shore communities.5,13,14 Amphipod gut content analyses reveal a diverse diet of sponges, 
filamentous and unicellular algae, macroalgae, and bryozoans with flexible feeding habits from 
Figure 2.1. Diagram showing the 
differentiation between the two habitats within 
(W) and below (B) the algal canopy. The 
shallower depths are dominated by macroalgae 
while deeper a higher ratio of invertebrates, 
such as sponges, are found. 
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specialization, omnivory, suspension feeding, to grazing.7,13,15-23 Light penetration in the trophic 
zone creates a dense macroalgal canopy (~3 m above the benthos)24,25 providing amphipods with 
a site for reproduction, shelter, and a source of direct and indirect nutrition.5,26-29 This shallow 
community supports a distinct amphipod habitat,13 but amphipods are less common below the 
infralittoral zone.16,23  
 
2.1.2 Chemical Defenses Employed by Antarctic Sponges 
Chemical defenses are a common means employed by sponges to deter predation.30-32 Examples 
from the Antarctic include the demosponge Latrunculia apicalis, which was found to produce 
discorhabdin G (2.1), which decreased feeding of the sea star Perknaster fuscus, a known sponge 
predator.33,34 Erebusinone (2.2), isolated from the Antarctic sponge Isodictya erinacea, reduced 
molting and increased mortality when introduced to the predatory amphipod Orchomene plebs.35 
Norselic acid A (2.3) from a Crella sp. sponge, significantly deterred feeding of the omnivorous 
amphipod Gondogeneia antarctica and sea star Odontaster validus.36 Deep water sponges 
including Mycale acerata, Isodictya verrucosa, Rossella figulata, and Iophon sp. revealed 
significant toxicity toward the sympatric sea urchin Sterechinus neumayeri.37 
 
Dendrilla membranosa (family Darwinellidae, order Dendroceratida) is among the common 
sponges in the Antarctic marine environment. Signs of predation toward this bright yellow 
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sponge are rare,7 and collections from around the continent have afforded a suite of diterpenoids 
(2.4- 2.13).38-41 Antibiotic activity was noted for membranolides A (2.10), C (2.12) and D (2.13) 
against Staphylococcus aureus, Escherichia coli and Candida albicans.38,41 In addition, 
methanolic extracts of D. membranosa containing 7-methyladenine (2.14) and picolinic acid 
(2.15) exhibited tube-foot retraction activity toward the spongivorous sea star P. fuscus.39 Further 
work showed that lipophilic extracts of D. membranosa displayed significant feeding deterrence 
toward G. antarctica.23 The defensive nature of these secondary metabolites constitutes an 
ecological advantage for D. membranosa. 
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2.1.3 Feeding Deterrence of Membranolide Diterpenes 
As previously stated, extracts of D. membranosa displayed feeding 
deterrence against the omnivorous and potentially spongivorous 
amphipod G. antarctica.39 Membranolide A (2.10) was tested at 
natural concentrations (0.2% dry weight38) in an alginate food 
mixture for feeding repellency towards G. antarctica (Figure 2.2) 
by Maschek.42 A significant deterrence (p ≤ 0.05) was established 
for 2.10 based on the Wilcoxon signed-ranked test.42 Considering 
that amphipods are among the major predators of WAP sponges,23 
membranolide A is likely biosynthesized to defend itself against 
amphipod predation. 
 
2.1.4 Habitat and Site Variability in the Chemical Ecology of D. membranosa 
Many investigations have found effects of ecological pressure on a variety of chemically 
defended marine organisms,43-53 including sponges.54-58 A study was undertaken to transplant 
fragments from a single Rhopaloeides odorabile sponge to various depths and locations along 
the Great Barrier Reef in Australia showing significant increases in diterpene production in 
shallower regions over their deeper counterparts.54 The chemically defended Indo-Pacific 
sponge, Stylissa massa, displayed intraspecific chemical diversity of its metabolites, but 
predation (in caging experiments) did not affect the secondary metabolite concentrations.57 
Various reefs throughout the Caribbean displayed a higher ratio of chemically defended versus 
undefended sponges in areas of increased spongivorous fish populations.59 
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Figure 2.2. Results of 
bioassays offering artificial 
foods containing 
membranolide A to the 
omnivorus amphipod G. 
antarctica. Significant 
difference (p ≤ 0.05) with 
control pellets preferred to 
extract pellets. 
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For omnivorous or spongivorous amphipods, the macroalgal canopy of the WAP provides refuge 
for amphipods from fish predation,60 but at the same time exposes sponges in that habitat to 
higher predator densities. In comparison to sponges occupying the more exposed habitat that 
exists at depths below the algal canopy, omnivorous amphipods might be expected to be less 
common due to the lack the refugia provided by macroalgal cover. Sponges in such a habitat 
might similarly be expected to modulate their chemical defenses in response to lower predator 
density. We postulate that D. membranosa found in shallower, amphipod rich waters adopt 
higher levels of defensive chemicals than sponges found below the algal canopy zone. We 
studied D. membranosa from both habitats at four distinct sites near Palmer Station, Antarctica 
to evaluate amphipod predation pressure and concomitant chemical defense profiles. The 
PRIMER-E v6 software suite61 was used for multidimensional scaling (MDS) plots to correlate 
site and habitat specificity in relation to amphipod abundance on individual sponges. Analysis of 
similarities (ANOSIM), similarity percentage (SIMPER), and biota and/or environment 
matching (BIOENV) were used to measure the statistical relationship between habitat, site, and 
amphipod densities.62 The defensive metabolites from D. membranosa were investigated 
including deterrence of amphipod predation and their spatial and geographical distribution. 
 
2.1.5 Results of Sponge Collection and Amphipod Quantification 
Sponge samples (20 individuals) were collected from four different locations around the WAP 
(Figure 2.3). Each specimen was examined and individual amphipods (~2700 total) were 
morphologically characterized down to the species level if possible. The results of these 
amphipod counts revealed 22 different taxa, six of them were deemed omnivorous or potentially 
spongivorous via the BIOENV procedure (Table 2.1, shaded in grey). 
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Figure 2.3. Map showing the four collection sites: Norsel Point (1), Bonaparte Point (2), Gamage Point 
(3) and Laggard Island (4) around Palmer Station (*) on the Western Antarctic Peninsula.
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2.1.6 Results of Metabolomic and Statistical Analysis of D. membranosa 
Sponge samples were extracted and subjected to LC/QToF-MS analysis for metabolomic 
fingerprinting; the secondary metabolites aplysulphurin (2.8), tetrahydroaplysulphurin (2.9), and 
membranolide A (2.10) were quantified in each sample. Diterpene concentrations were found to 
be highly variable even between biological replicates at the same site and habitat (Figure 2.4). 
The known feeding deterrent membranolide A (2.10) was the most abundant secondary 
metabolite averaging 1374 mg/kg DW. The other two metabolites, aplysulphurin (2.8) and 
tetrahydroaplysulphurin (2.9) averaged 27 and 918 mg/kg DW, respectively. None of the 
metabolites differed significantly between sites, however, 2.9 production was significantly 
higher within the algal canopy than below (unpaired t-test, p ≤ 0.05). 
 
Figure 2.4. Concentration of secondary metabolites from D. membranosa samples from the four 
collection sites within (W) and below (B) the algal canopy. Concentrations of diterpenes are represented 
as the amount of compound (in mg) per kg of dried sponge.  
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Cluster analysis of the metabolomic data using a dendrogram revealed a clear separation between 
the two habitats within and below the algal canopy (Figure 2.5). The sponges below the canopy 
show a 60% similarity while those within the canopy display a 30% similarity. An 80% 
dissimilarity between the two habitats was observed via a SIMPER test; thus confirming how 
sponges within the two regions differ chemically. A 1- and 2- way ANOSIM was used to analyze 
the relationship between metabolite abundance to habitat, site, and amphipod abundance, 
resulting in a global R value of approximately zero (R= |0.07|) for site and metabolite abundance. 
Site is not a significant factor but a global R of 0.57 for habitat confirms a significant correlation. 
However a few outliers could be observed, such as data point U (left center of Figure 2.5) that 
clustered with deeper sponges and had a leathery nonporous morphology and the lack of 
amphipods indicate an older or diseased sponge. This sample paired well with data point H that 
displayed an equivalent chromatographic profile and a similar morphology. Two sponges from 
Bonaparte Point [data point O (within the canopy) and data point C (below the canopy)] have 
nearly identical metabolomic fingerprints and concentrations of tetrahydroaplysulphurin (2.9), 
410 and 468 mg/kg DW for C and O, respectively. Data point R (below the canopy) had a 
significantly higher concentration of membranolide A, which grouped it with other chemically 
defended sponges within the canopy (data points M and O). 
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Figure 2.5. Dendrogram cluster analysis of the top 100 compounds from D. membranosa with sample 
[letter in brackets] within the canopy region ( ) and those from depths below the canopy region ( ); 
similarity is measured in percent similarity. 
 
A 2- way ANOSIM of depth and amphipod densities in relation to metabolite abundance gave a 
global R of approximately zero (R= |0.07|) for amphipod significance. Since the null hypothesis 
is rejected, a SIMPER analysis was applied and revealed 34.8% dissimilarity between the 
shallow and deep habitats. Since neither test provided evidence that amphipods are a significant 
factor, the BIOENV procedure was performed to assess which combination of amphipod species 
describes the divergence within the data set. This test identified seven statistically significant 
amphipods (Atylopsis orthodactyla, Gondogeneia antarctica, Liljeborgia sp., Oedicerotidae, 
Paradexamine fissicauda, Prostebbingia brevicornis, Prostebbingia gracilis) that best describe 
the diversity within the chemical data set. All of these amphipods sans Oedicerotidae were 
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deemed potential sponge predators, and the resulting MDS overlays the statistically significant 
amphipods as a bubble plot (Figure 2.6). 
 
Figure 2.6. 2D MDS plot of D. membranosa metabolomic profile overlaid with statistically significant 
omnivorous amphipod densities (gray circles). There is a clear distinction between sponge specimens 
within (W) the algal canopy (right) and specimens found at depths below (B) the canopy zone (left). 
 
2.1.7 Conclusions and Future Work 
The oxidized diterpenes isolated from Dendrilla membranosa provide an ecological benefit 
including feeding deterrence and antibacterial properties.38-41 In a complex ecosystem this 
chemical defense affords protection against potential predators; amphipods can be omnivorous or 
spongivorous23 and are more prevalent within the algal-dominated infralittoral zone.16 We have 
shown that habitat, within and below the algal canopy, along with concomitant amphipod density 
can influence the metabolism of D. membranosa.  
 
There are several stressors to acknowledge between the two habitats: UV light penetration, 
greater algal fouling, and higher amphipod densities. Some organisms produce mycosporine-like 
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amino acids (MAAs) which can protect the host from UV radiation63,64 and have been found in 
many Antarctic invertebrates.65 Concentrations of MAAs were not tested in this study but 
previous work showed moderate levels (424 µg/g DW) in D. membranosa from McMurdo 
Sound.66 It should be noted that diterpenes from D. membranosa are not strong absorbers of UV 
light and likely do not protect against photo-induced stress. In the phototropic region, dominated 
by macroalgae, sponges could mediate their chemistry to deter algal fouling, as was the case for 
the Australian sponge Rhopaloeides odorabile.54 However, it is not known whether D. 
membranosa produces compounds to ward off algal fouling or play a role in allelopathy, but this 
could warrant further investigation. Finally, extracts of D. membranosa have been previously 
shown to display deterrence to Antarctic sponge predators23,39,67 which constitutes a significant 
ecological advantage. Fractionation efforts have resulted in loss of activity39 but we have now 
identified the secondary metabolite membranolide A (2.10) as a feeding deterrent of G. 
antarctica at natural concentrations (Figure 2.2). It is possible mixtures of compounds have a 
synergistic effect in deterrence or that other compounds such as tetrahydroaplysulphurin (2.9), at 
higher concentrations within the canopy, deter amphipod feeding. Further work needs to be done 
to characterize other feeding deterrents against G. antarctica and other omnivorous amphipods. 
 
Secondary metabolites were quantified from sponges to understand whether a trend exists 
between habitat and amphipod abundance. The results (Figure 2.4) show no correlation, and in 
fact diterpene concentrations are highly inconsistent even between sponges collected from the 
same site and habitat. Membranolide A (2.10) had the highest average concentration and we 
suspected that it would be produced in higher abundance within the algal canopy, given its role 
as a feeding deterrent, but no such trend was observed. So, it is likely that D. membranosa 
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produces 2.10 constituently rather than in response to stress factors. Statistical analysis was 
employed to evaluate the correlation of amphipod predation to the chemical fingerprints. The six 
predatory amphipod taxa, identified by BIOENV, were all found on sponges that grouped 
(stress= 0.07) within the algal canopy (Figure 2.6). This is in agreement with previous reports 
that state amphipods are more abundant in algal-rich waters13 and in the circalittoral region 
amphipod numbers are lessened without the plentiful algal food source.16,23 Feeding deterrent 
metabolites likely play a role in clustering of the sponges within the algal canopy, as they are 
more likely to be preyed upon in this region. The amphipods are major sponge predators and 
may also play a role in mediating the metabolome of D. membranosa. These results also provide 
evidence for allelopathic properties of the metabolites, but further testing needs to be done to 
confirm this hypothesis. 
 
Our recent investigations of the red alga Plocamium cartilagineum68 and the nudibranch 
Austrodoris kerguelenensis69 found metabolic divergence between the individual species. In 
Antarctica glaciations can segregate regions causing genetic and chemical variability after 
multiple generations. Site specificity was an important factor in the metabolism of P. 
cartilagineum and was attributed to cryptic speciation, but unlike the current study no site 
specificity was observed in D. membranosa. Similar to the findings in A. kerguelenensis, the 
chemical clustering of D. membranosa seems to be related to predator interactions. 
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2.2 Artifacts of Aplysulphurin and Investigation of Antileishmanial Activity 
2.2.1 Leishmaniasis Background 
Leishmaniasis is a neglected tropical disease spread by sandflies containing the obligate protozoa 
of the Leishmania genus; there are 30 proven species of sandfly vectors and over 20 Leishmania 
spp. that are pathogenic towards humans.70 The WHO estimates that 1.3 million new cases and 
20000 to 30000 deaths occur annually encompassing 90 countries in the tropics, subtropics and 
southern Europe.71 Once bitten by an infected female phlebotominae sandfly, promastigotes are 
injected into the host and are then phagocytized by macrophages. The promastigotes transform 
inside the cell into amastigotes, which multiply and can infect other phagocytic cells. The vector 
ingests infected cells, through a blood meal, and continues the disease cycle. The infection 
manifests in humans in three disease forms: visceral leishmaniasis (VL), cutaneous leishmaniasis 
(CL), and mucosal leishmaniasis (ML). The most common form (CL) causes skin sores, while 
the most deadly (VL) affects internal organs and can be fatal if left untreated. Mucosal 
leishmaniasis is the least common form and occurs when cutaneous infections spread to mucous 
membranes.72 
 
Current treatment for leishmaniasis infection requires the use of sodium stibogluconate (2.16) 
and its relative meglumine antimonate, amphotericin B (1.38), miltofosine (2.17), and 
pentamidine (2.18). These drugs can have severe, adverse side effects (such as amphotericin B) 
and resistance is emerging as they are prescribed to more patients.73 The Leishmania parasite 
now has resistance pathways mapped out for each of the drugs mentioned and while the use of 
cocktails, a combination of drugs, can create more effective treatments, the need for new 
antileishmanial drugs is pressing. A screening program implemented in our laboratory attempted 
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to find hit-to-lead compounds by testing crude extracts and pure compounds in vitro against L. 
donovani axenic amastigotes. It was found that aplysulphurin and is methoxy artifacts possess 
selective and potent activity against the parasite. 
 
 
2.2.2 Origin of the Methoxy-bearing Membranolides 
Membranolides B-D (2.8-2.12) were originally described from D. membranosa in 200441 and 
later membranolides E-H (2.19-2.22) were isolated.42 Membranolides B (2.11), C (2.12), D 
(2.13), E (2.19), F (2.20), G (2.21), and H (2.22) all contain at least one methoxy group on the 
furan or lactone ring systems. The orientation of these groups seem particularly suspect since 
having several forms of these diastereomers is unlikely to occur biosynthetically. We reported in 
2004 that freeze-dried sponge, extracted in ethanol, resulted in no ethyl acetal compounds thus 
ruling out the possibility of solvent-influenced artifacts. More recently, we have observed that 
LCMS analysis of DCM extracted D. membranosa treated with MeOH resulted in new peaks 
with masses matching the methoxy membranolides and decreased abundance of aplysulphurin. 
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Continuing the work of Maschek42 the degradation of aplysulphurin into the methoxy 
membranolides was investigated. 
 
 
To further investigate the origin of these methoxy-bearing membranolides, aplysulphurin was 
dissolved in MeOH and the LC chromatogram (Fig. 2.7) was obtained, bearing new peaks in the 
range of 4-5 min with mass spectra corresponding to the methoxy-substituted membranolides. 
Further confirmation was achieved visualizing 1H NMR spectra with characteristic methoxyl 
(3.3-3.8 ppm) and acetal (5.9-6.4 ppm) signals present. This prompted a full-scale study using 
aplysulphurin (24 mg) as the starting material. 
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Figure 2.7. LCMS chromatogram of aplysulphurin (AS, 2.8) before (top) and after (bottom) a 12 hour 
treatment with MeOH. 
 
After 24 hours of 2.8 MeOH treatment, at rt without stirring, a white powder was obtained after 
evaporation of the solvent in vacuo. Purification with HPLC yielded all of the methoxy 
membranolides (Table 2.2). Aplysulphurin was obtained in 60% recovery while membranolide B 
was the highest yielding product (21% yield) and all other methoxy-substituted membranolides 
were found in <5% yield. Membranolide A was not present in the degradation mixture, so its role 
as a natural product and feeding deterrent is substantiated. Membranolide B (2.11) is stabilized 
by having its methoxy group in a pseudo-axial position on the lactone ring, this stability is likely 
responsible for its high yield. The di-methoxy-substituted membranolides (2.12, 2.13, 2.21, and 
2.22) are very labile and often decomposed to the more stable membranolide B under mild 
oxidative conditions (such as drying under N2).  
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Table 2.2. 1H NMR spectral and optical rotation comparison of the methoxy-bearing membranolides B-H 
to literature values.41-42 
 
C"H$Position Literature$$$
memranolide$B 2.11
Literature$$$$
membranolide$C 2.12
Literature$$$$
membranolide$D 2.13
Literature$$$$
membranolide$E 2.19
1 1.51,$m 1.52,$m 1.45,$m 1.45,$m 1.53,$m 1.52,$m 1.5,$m 1.5,$m
2.23,$m 2.25,$m 2.29,$br$d 2.28,$m 2.29,$m 2.29,$m 2.24,$m 2.25,$m
2 1.67,$m 1.63,$m 1.65,$m 1.62,$m 1.63,$m 1.64,$m 1.67,$m 1.65,$m
1.72,$m 1.74,$m 1.8,$m 1.8,$m 1.74,$m 1.78,$m 1.74,$m 1.75,$m
3 1.33,$m 1.33,$m 1.26,$m 1.27,$m 1.33,$m 1.33,$m 1.33,$m 1.33,$m
1.32,$m 1.33,$m
4
5 1.58,$d$(14.5) 1.58,$d$(14.5) 1.49,$d$(14.0) 1.49,$d$(14.0) 1.49,$m 1.49,$m 1.58,$m 1.56,$m
2.05,$d$(14.5) 2.08,$d$(14.5) 2.09,$d$(14.0) 2.08,$d$(14.0) 2.08,$m 2.07,$m 2.07,$m 2.07,$m
6
7 4.53,$q$(7.5) 4.55,$q$(7.5) 4.69,$q$(7.0) 4.67,$q$(7.0) 4.6,$q$(7.0) 4.55,$q$(7.0) 4.58,$q$(7.0) 4.57,$q$(7.0)
8
9
10
11 7.75,$d$(8.5) 7.77,$d$(8.5) 7.57,$d$(8.0) 7.55,$d$(8.0) 7.38,$d$(8.0) 7.52,$d$(8.0) 7.77,$m 7.77,$m
12 7.72,$d$(8.5) 7.74,$d$(8.5) 7.25,$d$(8.0) 7.2,$d$(8.0) 7.08,$d$(8.0) 7.15,$d$(8.0) 7.75,$m 7.74,$m
13
14
15 6.8,$s 6.84,$s 5.89,$s 5.86,$s 6.26,$s 6.25,$s 7.24,$s 7.25,$s
16 10.05,$s 10.07,$s 5.86,$s 5.85,$s 5.9,$s 5.81,$s 10.1,$s 10.08,$s
17 1.81,$d$(7.5) 1.83,$d$(7.2) 1.59,$d$(7.0) 1.7,$d$(7.0) 1.85,$d$(7.0) 1.85,$d$(7.0) 1.88,$d$(7.0) 1.84,$d$(7.0)
18 0.57,$s 0.59,$s 0.47,$s 0.46,$s 0.48,$s 0.47,$s 0.6,$s 0.59,$s
19 0.96,$s 0.98,$s 0.92,$s 0.96,$s 0.85,$s 0.86,$s 0.99,$s 0.99,$s
20 1.25,$s 1.44,$s 1.39,$s 1.39,$s 1.38,$s 1.4,$s 1.34,$s 1.34,$s
21 3.8,$s$ 3.82,$s 3.47,$s 3.46,$s 3.37,$s 3.36,$s 3.5,$s 3.5,$s
22 3.5,$s 3.49,$s 3.35,$s 3.34,$s
Optical$
Rotation
"121.0 "118.4 "100.8 "18.5 +6.5 +6.8 N/A "50.2
C"H$Position
Literature$$$
memranolide$F 2.20
Literature$
membranolide$G 2.21
Literature$
membranolide$H 2.22
1 1.5,$m 1.53,$m 1.5,$m 1.52,$m 1.5,$m
2.32,$m 2.27,$m 2.26,$m 2.25,$m 2.25,$m
2 1.65,$m 1.65,$m 1.65,$m 1.68,$m 1.62,$m
1.83,$m 1.74,$m 1.75,$m 1.78,$m 1.75,$m
3 1.33,$m 1.4,$m 1.33,$m 1.32,$m 1.36,$m 1.37,$m
4
5 1.56,$m 1.58,$m 1.47,$m 1.5,$m 1.49,$m 1.42,$m
2.14,$m 2.15,$m 2.07,$m 2.08,$m 2.05,$m 2.04,$m
6
7 4.73,$q$(6.7) 4.76,$q$(7.0) 4.57,$q$(6.7) 4.57,$q$(6.8) 4.54,$q$(7.0) 4.45,$q$(7.0)
8
9
10
11 7.75,$d$(8.3) 7.76,$d$(8.0) 7.51,$d$(8.0) 7.57,$d$(8.0) 7.47,$d$(8.0) 7.47,$d$(8.0)
12 7.75,$d$(8.3) 7.79,$d$(8.0) 7.16,$d$(8.0) 7.22,$d$(8.0) 7.13,$d$(8.0) 7.12,$d$(8.0)
13
14
15 6.14,$s 6.15,$s 6.1,$s 6.14,$s 6.04,$s 6,$s
16 6.27,$s$ 6.3,$s 5.94,$s$ 5.8,$s
17 1.73,$d$(7.1) 1.76,$d$(7.0) 1.67,$d$(7.2) 1.7,$d$(7.2) 1.57,$d$(7.2) 1.6,$d$(7.2)
18 0.48,$s 0.49,$s 0.46,$s 0.49,$s$ 0.38,$s 0.34,$s
19 0.95,$s 0.96,$s 0.87,$s 0.93,$s 0.83,$s 0.84,$s
20 1.42,$s 1.44,$s 1.38,$s 1.41,$s 1.3,$s 1.25,$s
21 3.59,$s 3.64,$s 3.36,$s 3.34,$s 3.38,$s 3.4,$s
22 3.27,$s 3.43,$s 3.34,$s 3.36,$s
Optical$
Rotation
+135.0 +86.6 +33.0 +18.9 "37.0 "18.4
1.83,$m
δH$(J"Hz) δH$(J"Hz) δH$(J"Hz) δH$(J"Hz)
δH$(J"Hz) δH$(J"Hz) δH$(J"Hz)
2.33,$m
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A mechanism for the formation of the methoxy artifacts from aplysulphurin (2.8) is outlined in 
Figure 2.8. Attempts to generate ethoxy artifacts using neat EtOH were unsuccessful, however, 
the reaction could be catalyzed by a small amount (0.1%) of acetic acid or pyridine. Because of 
the similar characteristics and properties of MeOH and EtOH this result is rather surprising. The 
slightly larger size of EtOH could hinder the nucleophilic attack (step 5, Figure 2.8) of the 
aldehyde to form the six-membered lactone ring. Alternatively, an oxonium ion could be formed 
in the lactone ring with acid or base to help overcome this high-energy activation barrier. From 
this point the more sterically encumbered EtOH would be free to attack the lactone ring or the 
aldehyde to form the corresponding ethyl acetal artifacts. Studies with membranolide B in 
MeOH showed that aplysulphurin could not be formed, even when supplemented with acetic 
acid, meaning that the equilibrium in this reaction is shifted towards 2.11 as the di-methoxy-
substituted membranolides also form 2.11 in oxidative conditions. 
 
Figure 2.8. Proposed mechanism of aplysulphurin (2.8) degradation into methoxy-bearing 
membranolides B (2.11), C (2.12), D (2.13), E (2.19). G (2.21), and H (2.22). 
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2.2.3 Leishmaniasis Activity of D. membranosa Natural Products and Artifacts 
The suite of membranolides were tested for bioactivity against L. donovani axenic amastigotes in 
the hope of determining a structure-activity relationship. To test for cytotoxicity, compounds 
were also screened for inhibition of growth in mammalian Vero cells. The results (Table 2.3) 
point to potent bioactivity for membranolides G (2.21) and H (2.22) with IC50 values against L. 
donovani of 0.82 and 1.14 µM, respectively. In addition, both display a high SI 
(cytotoxicity/antiprotozoal activity) of 64.8 and 46.6 for membranolides G and H, respectively. 
Both of these compounds have comparable activity to the standard treatments of amphotericin B 
and miltefosine and are more active than its precursor aplysulphurin (IC50= 1.56 µM) with a 
higher SI (30.6). Another fascinating discovery from this screening was the lack of activity in 
membranolides C (2.12) and D (2.13). Structurally, they are diastereomers of membranolides G 
and H but their methoxy groups are staggered on the furan ring. The orientation of the methoxy 
groups is crucial for the potency of these compounds. Future studies can further evaluate these 
compounds and understand their target and mechanism of action. 
Table 2.3. IC50 values for D. membranosa natural products and artifacts against L. donovani axenic 
amastigotes and cytotoxicity against Vero cells. Amphotericin B (0.38 µM) and miltefosine (3.35 µM) 
were used as positive controls against L. donovani. 
 
 
 
Leishmania)donovani Vero%Cell
Aplysulphurin 1.56 47.7
Tetrahydroaplysulphurin 17.3 53.3
Membranolide%A Inactive >58.1
Membranolide%B 58.1 44.3
Membranolide%C >53.1 40.7
Membranolide%D >53.1 40.7
Membranolide%F 26.7 42.4
Membranolide%G 0.82 >53.1
Membranolide%H 1.14 >53.1
IC50%Values%(μM)Compound
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2.2.4 Conclusions and Future Work 
We now have reported that membranolides B-H are all artifacts from methanolic degradation of 
aplysulphurin. While this occurrence in the extraction of natural products is rare, there are two 
other reports noting MeOH-derived artifacts including the tambjamines74 and withanolides.75 
The isolation of these artifacts has identified a suite of methoxy-bearing membranolides 
possessing potent activity against the parasite L. donovani. More material will be needed to 
understand the mechanism of action of these compounds and for in vivo testing. Collaborative 
work is currently underway to synthesize membranolide and to screen new analogues utilizing a 
structure-activity relationship to clearly identify and optimize a lead compound. 
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Chapter 3. Co-culture Induced Secondary Metabolites from a Marine-derived 
 
Bipolaris sp. Fungus 
3.1 Co-culture Background 
The OSMAC approach1 has become a popular method to increase the chemodiversity of a 
microorganism library. By making minor changes during cultivation (vessel size, temperature, 
salinity, aeration etc.) chemical titers can be altered and optimized, creating a virtually limitless 
potential for secondary metabolites. These abiotic factors can easily be manipulated and 
instrumentation such as fermenter could be implemented to strictly monitor and control culture 
conditions. However a biotic stressor, such as another microbe, can elicit a defensive response 
for upregulation of secondary metabolites and awaken cryptic biosynthetic pathways.2 
 
Mixed fermentations have been utilized in industrial settings for food production and wastewater 
treatment, which have increased efficiency and decreased costs.3,4 But co-culturing can be 
advantageous and profitable in drug discovery applications as well. The discovery of penicillin 
(1.33) turned out to be one of the greatest revolutions in modern medicine.5 Fleming’s initial 
discovery was noted as a Penicillium notatum mold contaminant, which inhibited the growth of 
Staphylococci colonies on a petri dish. A clear zone of inhibition was observed between the two 
organisms in addition to bacterial cell lysis. This co-culture, intended or not, led to the discovery 
of a potent antibacterial that is still utilized today. To date, there are several reports of co-cultures 
providing new bioactive natural products. 
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Aspergillus fumigatus and a Spingomonas sp. bacterium were isolated from a heavily 
contaminated mine drainage site, and were cultured together.6 After 15 days of incubation in 
liquid cultures, purification resulted in a suite of diketopiperazine disulfides including glionitrin 
(3.1), gliotoxin (3.2), and dehydrogliotoxin (3.3). Antimicrobial assays showed modest activity 
of 3.1, which also exhibited submicromolar cytotoxic activity against four human cancer cell 
lines. Another A. fumagtus fungus and a Streptomyces peucetius bacterium were co-cultured after 
a noticeable zone of inhibition was observed on solid media.7 Time course studies were 
optimized and two new N-formyl alkaloids were isolated, fumiformamide (3.4) and N,N’-
((1Z,3Z)-1,4-bis(4-methoxyphenyl)buta-1,3-diene-2,3-diyl)diformamide (3.5). Both compounds 
were screened against the NCI-60 cell line panel and were found to display submicromolar 
cytotoxicity. 
 
A Pestolia fungus and a Gram-negative marine bacterium were co-inoculated into marine-based 
medium and a novel benzophenone, pestalone (3.6) was isolated.8 Nanomolar potency was noted 
against MRSA and VRE. It was found that this compound could be induced from the fungus by 
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the addition of EtOH to the cultures, signifying its role in stress response. The same bacterium 
used in the aforementioned study was pitted against a Libertella fungus and a suite of pimarane 
diterpenes were isolated, libertellenones A-D (3.7-3.10), but only 3.10 displayed bioactivity 
against a cancer cell line.9 
 
Two new depsipeptides were isolated from co-cultures of Salinospora arenicola and an 
Emericella fungus.10 Emericellamides A (3.12) and B (3.11) were upregulated 100-fold in co-
cultures which aided in their isolation and characterization; both had moderate antimicrobial and 
cytotoxic activity. Fusarium tricinctum and the potentially pathogenic Bacillus subtilis were co-
cultured in rice media and three new compounds, macrocarpon C (3.13), 2-
(carboxymethylamino) benzoic acid (3.14), and (-)-citreoisocoumarin (3.15), could only be 
induced by F. tricinctum through competitive culturing with B. subtilis. Other bacteria could not 
elicit production of these compounds despite them all having moderate broad-spectrum antibiotic 
activity. 
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3.2 Isolating Endosymbiotic Microorganisms 
Endophytes are bacteria or fungi that colonize plants or algae without causing harm to the host 
organism.11 The suffix “-phyte” describes a plant-like association, but symbiotic microorganisms 
can colonize many different living organisms; these microbes will be further denoted as 
endosymbionts. Many of the undescribed microorganisms are presumed to be endosymbionts or 
“unculturable” in laboratory settings.12-13 The ocean teems with microbial diversity (one mL of 
seawater contains 104 to 106 bacteria) that can colonize a wide variety of substrates,14 and 
endosymbionts have been identified from nearly every marine phylum.15-22 Endosymbionts not 
only represent a diverse source of microbes, but also an understudied reservoir of potent 
bioactive natural products. 
 
The microtubule-stabilizing antitumor agent, paclitaxel (1.32) was originally isolated from the 
bark of the Pacific yew tree, however, low yields required large quantities of these slow-growing 
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trees to be stripped and killed.23 Investigations of the leaves and needles provided higher 
quantities of the precursor, baccatin, but a more renewable resource was needed. A fungal 
endophyte, Taxus brevifolia, was isolated from the bark of the yew tree and 1.32 was confirmed 
by microbial production after the addition of yew needles to cultures.24 Trabectidin (1.39) and 
bryostatin 1 (1.40) are marine-derived drugs from a tunicate and bryozoan, respectively, but both 
have been attributed to microbial production via genomic methods.25,26 Though these microbes 
were not culturable in the laboratory, the exploration of endosymbionts can yield a diverse 
microbial library with bioactive natural products. 
 
3.3 Bellows Gulf Cruise 2011 (BGC11) and Bioactivity Screening 
In May 2011, a collection trip was undertaken in the Dry Tortugas west of the Florida Keys 
(Figure 3.1) to collect marine invertebrates by SCUBA. Eight sites were sampled and 81 
macroorganisms were collected. Surface sterilization and isolation procedures for endosymbiotic 
microorganisms have been reported.27,28 Sponges were squeezed to remove all saltwater, placed 
in sterile saltwater, then sprayed with IPA and allowed to air dry. Tunicates, corals and algae 
were set in IPA for 30s and rinsed with sterile saltwater. Now sterilized, small pieces (1 mm2) of 
each organism were cut and placed in quadruplicate on four agar types: SDA, ACT, DMA, and a 
nutrient deficient salt media with the addition of antibiotics to slow the growth of fast-growing 
organisms. The agar plates were set aside to facilitate microbial growth. Fungal isolates were 
aseptically transferred to Sabouraud dextrose agar (SDA) while bacterial isolates were plated on 
trypticase soy agar (TSA). In total 559 microorganisms were isolated, 501 being bacteria and the 
remaining 58 were fungi. 
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Figure 3.1. Map showing the eight dive sites (green lettered arrows) from the Dry Tortugas selected for 
sampling for Bellows Gulf Cruise 2011. Obtained from maps.google.com. 
 
The fungal isolates were incubated on SDA for 21 days at 30 °C. The agar and fungal mycelia 
were lyophilized and subjected to triplicate MeOH extractions. These crude extracts were tested 
against various microbial pathogens for antibiotic activity at 1 mg in a Kirby-Bauer disk 
diffusion assay. A brine shrimp assay for cytotoxicity29 was performed at concentrations of 500, 
100 and 10 ppm. Of the 36 fungal extracts tested, seven were cytotoxic to brine shrimp at 10 
ppm concentration, two were active against Aspergillus niger, and two displayed activity against 
Bacillus subtilus. Co-cultures were initiated on SDA with active BGC11 fungi against either A. 
niger or B. subtilus (Figure 3.2). One isolate (BGC11-58B-5) was obtained as a brown 
filamentous fungus from actinomyces (ACT) media plates containing plugs of surface sterilized 
Xestospongia muta sponge. The co-culture of A. niger and BGC11-58B-5 resulted in a zone of 
inhibition with A. niger growth being significantly repelled by the marine endosymbiotic fungus 
(Figure 3.2, B). This result prompted further investigations of the two organisms.   
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Figure 3.2. Co-culture screenings from BGC11 isolates. A) BGC11-56A-2 fungus (white, center) pitted 
against four bacteria, inhibition observed between one Bacillus sp. (left). B) Fungal inhibition observed 
between BGC11-58B-5 (bottom) and A. niger (top). 
 
3.4 Co-culture Optimization and Scale-up Production 
The fungal isolate (BGC11-58B-5) was subjected to 
DNA extraction, and 18S ribosomal RNA sequencing 
revealed a 99% match to Bipolaris sp. Extensive studies 
were undertaken to optimize the production of defensive 
secondary metabolites by evaluating LCMS spectra and 
bioactivity profiles. The major culture parameters altered 
were the co-inoculation times, incubation times, and 
media type (liquid vs. solid). Similar bioactivity against 
A. niger was observed regardless of the parameters  
selected, but inoculation of A. niger into Bipolaris cultures after three days yielded the highest 
extract masses. Scale-ups were initiated using both liquid and solid SDA and the results (Figure 
3.3) showed much higher extract masses in solid-state co-cultures despite less growth media 
being used. In addition, solid-state allows for the excision of both fungi and the zone of 
Figure 3.3. Yields of co-culture 
extracts in liquid and solid SDA. 
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inhibition to understand the origin of the metabolites and whether they are exuded extracellularly 
as a defense mechanism. 
 
3.4.1 Compounds Isolated from Bipolaris sp. 
The solid-state co-cultures were excised into three regions (Bipolaris sp., A. niger, and zone of 
inhibition) before lyophilization and MeOH extraction. The Bipolaris MeOH extract (6.24 g) 
was partitioned between EtOAc and H2O to yield 1.37 g of the organic extract. From this fraction 
the known compounds alternariol (3.16), alternariol methyl ether (3.17), altenuene (3.18), and 
ascospiroketal A (3.19) were identified according to their 1H NMR and MS spectra, and optical 
rotation. In addition, the new compounds bipolarolides A (3.20), B (3.21), and C (3.22) were 
elucidated with extensive spectroscopic analysis. The isolation scheme for these compounds is 
outlined in Scheme 3.1. 
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Scheme 3.1. Isolation scheme for polyketide secondary metabolites from Bipolaris sp. 
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The suite of alternariols have been well described and occur commonly in the Alternaria genus 
of fungi and are known mycotoxins.30 The 1H NMR and MS comparison of compounds 3.16- 
3.18 were in good agreement with the literature values (Figure 3.4).31-32 The planar structure of 
3.18 was established with ROESY correlations from the methyl group at H-7’ to that of the 
hydroxyl proton at C-4’ and to H-5’. Additionally, optical rotation was taken (c= 0.2, DCM) and 
the experimental value of [α]20D -5.1 matched with the literature value of [α]25D -7.8 (c= 0.2, 
DCM). 
 
Figure 3.4. 1H NMR comparison of alternariol (3.16), alternariol methyl ether (3.17), and altenuene 
(3.18) to literature values and HRMS. Spectra recorded at 500 MHz. 
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The ascospiroketals, containing the unique tricyclic ring structure, have only been reported once 
from a marine-derived Ascochyta salicorniae fungus.33 Both the 1H NMR and HRMS data are in 
good agreement with the reported values (Figure 3.5). Despite the lack of stereochemistry of the 
side chain ester the relative configuration of 3.19 was confirmed through interpretation of 1D 
and 2D 1H-1H correlations. The double bond geometry was confirmed through 1H-1H coupling 
constants with C10,11 being E configured (J10,11= 15.1 Hz) while C12,13 being Z configured (J10,11= 
11.0 Hz). The stereocenters within the ring system were established through NOESY correlations 
of H-4, H-3, and H-17 indicating all were oriented on the same side of the scaffold. Irradiation of 
H-3 gave enhancement of the resonances of H2-7, and irradiation of H-9 caused enhancement of 
H2-5 giving the relative configuration of the ring system. Finally, optical rotation supported this 
proposed structure with a value of [α]20D  +30 (c= 0.4, MeOH) in close proximity to the reported 
value of [α]25D +20 (c= 0.45, MeOH). 
 
Figure 3.5. 1H NMR comparison of ascospiroketal A (3.19) to literature values. Spectra recorded at 500 
MHz in CDCl3 and HRMS, literature reported in (CD3)2CO. 
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Bipolarolide A (3.20) was obtained (0.6 mg) as a white gum with the molecular formula 
C16H24O5 calculated from m/z 297.1697 (five degrees of unsaturation) 
as determined by the HRESIMS [M + H]+ ion at m/z 297.1701. The 
13C NMR data (Table 3.1) revealed the presence of two ester 
carbonyls (δC 177.0 and 176.0) as well as four olefinic carbons  
(δC 130.8, 129.7, 128.6, 127.7) leaving only one degree of saturation 
unassigned. The side chain of (3.20) was identical to ascospiroketal A 
(3.19), but a lactone ring was deduced through HMBC correlations  
from H-2, H-3 and H-4 to C-1 (δC 177.0) along with 1H-1H COSY  
correlations from H-4 (δH 5.00) to Hab-3 (δH 2.42 and 2.01) and H-5 (δH 5.71) (Figure 3.6). The 
configuration of the conjugated diene was established from the 1H-1H coupling constants; J5, 6= 
15.1 Hz suggests an E configuration and J7, 8= 11.0 Hz suggests a Z configuration. The Z 
configuration was also confirmed through 1D NOE analysis by irradiation of H-7 (δH 6.11) to 
reveal a strong correlation to H-8 (δH 5.51). 
 
The relative stereochemistry of positions C-2’ and C-3’ could be elucidated by the spin-coupling 
constants (3JH, H) using Murata’s method.34 The coupling constant associated between C-2’ and 
C3’ was measured at 4.0 Hz suggesting a dihedral angle of 60° 
between the neighboring groups. Each diastereomer was energy 
minimized and only two enantiomeric syn-conformed structures 
displayed a dihedral angle congruent with the coupling constant 
between C-2’ and C-3’. Interestingly, the position of the methyl group 
at C-10 had to be anti to the adjacent functionalities for the dihedral  
O
O
OH
O
O
Figure 3.7. Proposed 
stereochemistry of 3.20 
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O
OH
O
O1
4
10
11
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Figure 3.6. Key COSY 
(bold) and HMBC 
(arrow) correlations 
needed for structure 
elucidation of 3.20. 
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angle to be met (see Figure 3.7).  Lack of material hindered attempts at hydrolysis of the ester as 
well as derivatization with Mosher’s reagent for the absolute configuration. Attempts to 
crystallize (3.20) have been unsuccessful so the configuration at C-4 remains unassigned due to 
the flexibility at this position. 
Table 3.1. NMR spectral data for bipolarolides A (3.20) and B (3.21) in CDCl3. 1H spectra recorded at 
600 MHz, 13C recorded at 150 MHz. 
 
 
 
Bipolarolide B (3.21) was obtained (0.8 mg) as a white gum with the chemical formula C18H26O6 
calculated from m/z 339.1796 established by HRESIMS of the 
[M + H]+ ion at m/z 339.1796. The 1H and 13C NMR data (Table 
3.1) were nearly identical to (3.20) with one additional proton 
resonance δH 2.01 (3H, s) and ester δC 170.0 indicative of an 
acetate group. In addition, the proton at C-3’ was shifted 
downfield from (3.20) to δH 5.16 (1H, qd, J= 6.5, 2.6 Hz), 
bipolarolide*A*(3.20)* bipolarolide*B*(3.21)*position* δC,*type* δH*(J"in*Hz)* HMBC* δC,*type* δH*(J"in*Hz)* HMBC*1* 177.0,*C* 176.7,*C*2* 28.4,*CH2* 2.55,*m* 1,*3* 34,*CH2* 2.52,*m* 1,*3*3* 28.8,*CH2* 2.42,*2.01*m* 1,*2,*4* 28.5,*CH2* 2.40,*2.00,*m* 1,*2,*4*4* 80.3,*CH* 5.00*m* 3,*5* 80.4,*CH* 5.03,*q*(7.3)* 3,*5*5* 130.8,*CH* 5.71,*dd*(15.1,*6.6)* 4,*6* 130.6,*CH* 5.71,*dd*(15.1,*6.6)* 4,*6*6* 127.7,*CH* 6.59,*dd*(15.1,*11.0)* 4,*7,*8* 127.8,*CH* 6.60,*dd*(15.1,*11.0)* 4,*7,*8*7* 129.7,*CH* 6.11*dd*(11.0,*11.0)* 5,*9* 129.4,*CH* 6.1,*dd*(11.0,*11.0)* 5,*9*8* 128.6,*CH* 5.51,*dt*(11.0,*7.8)* 6,*10* 128.7,*CH* 5.52,*dt*(11.0,*7.8)* 6,*10*9* 34.1,*CH2* 2.51,*2.41,*m* 7,*8,*10,*11* 34.0,*CH2* 2.52,*2.42,*m* 7,*8,*10,*11*10* 70.4,*CH* 4.99,*m* 1',*8,*11* 70.1,*CH* 4.98,*p*(6.5)* 1',*8,*11*11* 19.7,*CH3* 1.26,*d*(6.3)* 9,*10* 17.6,*CH3* 1.25,*d*(6.5)* 9,*10*1'* 176.0,*C* 172.6,*C*2'* 45.6,*CH* 2.46,*m* 1',*3',*4',*5'** 44.4,*CH* 2.57,*m* 1',*3',*4',*5'**3'* 67.9,*CH* 4.05,*qdd*(6.5,*4.0,*4.0)* 1',*2',*4',*5'* 70.9,*CH* 5.16,*qd*(6.5,*2.6)* 1',*2',*4',*5'*4'* 19.8,*CH3* 1.17,*d*(6.5)* 2',*3'* 19.4,*CH3* 1.23,*d*(6.9)* 2',*3'*5'* 11.1,*CH3* 1.15,*d*(6.5)* 1',*2',*3'* 12.2,*CH3* 1.17,*d*(6.9)* 1',*3'*6'* 170.0,*C*7'* 20.9,*CH3* 2.01,*s* 6'*
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making this the position of the new acetate moiety as corroborated by HMBC analysis (Figure 
3.8). The double bond geometry is the same as (3.20) with J5, 6=15.1 Hz and J7, 8=11.0 Hz (E and 
Z configured, respectively). Unfortunately, energy minimization involving the neighboring 
stereocenters at C-2’ and C-3’ did not yield a structure with a dihedral angle (60°) congruent 
with the coupling constants (J= 2.6 Hz). As well, a crystal structure of could not be obtained so 
the stereochemistry of 3.20 remains ambiguous.  
 
Bipolarolide C (3.22) was obtained (0.5 mg) as a white powder with the chemical formula 
C18H30O5 calculated from m/z 349.1985 (four degrees of unsaturation) established by HRESIMS 
of the [M + Na]+ ion at m/z 349.1953. The 1H NMR data (Table 3.2) displayed four olefinic 
protons δH 5.70 (1H, dd, J= 16.0 and 9.1 Hz), δH 5.67 (1H, dd, J= 
15.3 and 7.5 Hz), δH 5.49 (1H, dd, J= 15.3 and 5.8 Hz), and δH 
5.35 (1H, dd, J= 16.0 and 8.0) and three methyl groups δH 1.33 (s), 
δH 1.19 (s), and δH 0.90 (t, J= 6.9 Hz). The 13C data (Table 3.2) 
showed one ester-type resonance (δC 176.8) and four oxygenated 
carbons (δC 79.8, 77.0, 74.0, and 71.5). The side chain of 3.22 was 
deduced through 1H-1H COSY correlations (Figure 3.9) from H-8 to 
H-16 as well as within the lactone ring H-3 to H-7. The HMBC 
correlation from H-3 to C-2 (δC 52.8) was observed as well as the correlation of gem dimethyl 
group protons (H-17 and H-18) to C-2 (δC 52.8) and C-1 (δC 176.8). The critical ring junction 
was confirmed by the HMBC correlation from H-8 to C-1 (δC 176.8), thus satisfying the final 
degree of unsaturation. Both double bonds are of the E geometry from the 1H-1H coupling 
Figure 3.9. Key COSY 
(bold) and HMBC (arrow) 
correlations needed for 
structure elucidation of 3.22. 
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constants (J4, 5= 16.0 Hz and J9, 10= 15.3 Hz). To date, crystallization attempts of 3.22 are 
underway yet none have proven effective for single crystal X-ray diffraction analysis. 
 
Table 3.2. NMR spectral data for bipolarolide C (3.22) in CD3OD. 1H spectra recorded at 600 MHz, 13C 
recorded at 150 MHz. 
 
3.4.2 Compounds Isolated from A. niger 
The solid-phase co-cultured A. niger MeOH extract (2.18 g) was partitioned between EtOAc and 
H2O to yield 667 mg of an organic soluble fraction. Purification of this fraction using NP MPLC 
and RP HPLC yielded the known pentapeptides malformins A1 (3.23), B4 (3.24) and the new 
malformin D (3.25) (Scheme 3.2). These compounds were elucidated using TOCSY, HMBC, 
NOESY, and Marfey’s analysis. Marfey’s analysis (Scheme 3.3) is a common method for 
determining the configuration of individual amino acids of a peptide using a chiral derivatizing 
agent after hydrolysis and analyzing their retention times via RP HPLC.35 All of the malformins 
contain varying ratios of Cys, Ile, Leu, and Val so each of these were used as standards, but 
bipolarolide*C*(3.22)*
posi/on* δC,*type* δH*(J"in*Hz)* HMBC*
1* 176.8,*C*
2* 52.8,*C*
3* 79.8,*CH* 3.88,*d*(9.1)* 2,*4,*17,*18*
4* 132.5,*CH* 5.70,*dd*(16.0,*9.1)* 6*
5* 135.0,*CH* 5.35,*dd*(16.0,*8.0)* 4*
6* 74.0,*CH* 4.10,*t*(8.0)* 4*
7* 37.0,*CH2* 1.90,*1.62,*m* 6,*8*
8* 77.0,*CH* 5.17,*t*(5.8)* 1,*7,*9,*10*
9* 132.3,*CH* 5.49,*dd*(15.3,*5.8)* 8*
10* 129.2,*CH* 5.67,*dd*(15.3,*7.5)* 8*
11* 41.0,*CH2* 2.15,*td*(15.3,*7.5)* 10,*12,*13*
12* 71.5,*CH* 3.56,*p*(5.8)* 10*
13* 39.7,*CH2* 1.40,*1.36,*m* 12,*14*
14* 29.6,*CH2* 1.33,*m* 13,*15*
15* 19.0,*CH2* 1.30,*m* 14,*16*
16* 14.0,*CH3* 0.90,*t*(6.9)* 13,*14,*15*
17* 16.4,*CH3* 1.33,*s* 1,*2,*3,*18*
18* 23.0,*CH3* 1.19,*s* 1,*2,*3,*17*
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cysteic acid was used since the disulfide bond must be oxidized with performic acid before 
hydrolysis, which can lead to racemization.36  
 
Scheme 3.2. Isolation scheme for malformins A1, B4, and D from A. niger. 
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Scheme 3.3. Synthetic steps for Marfey’s determination of D- and L- amino acid configuration using 
HPLC retention time analysis. 
 
 
Malformin A1 (3.23) was first described in 195837 and was named because it caused a 
malformation of corn roots while it also has cytotoxic and antibacterial properties.38,39 The NMR 
data (Table 3.3) of 3.23 isolated here matches that of the literature values40 and a TOCSY 
experiment confirms the presence of two Cys, one Ile, one Leu, and one Val residue. Marfey’s 
analysis revealed the absolute configuration of two D-Cys, one L-Ile, one D-Leu, and one L-Val 
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residue matching the sequence and configuration of malformin A1. Malformin B4 (3.24) found 
here had identical 1H NMR shifts with respect to published spectra.41 This initial assumption was 
confirmed after Marfey’s analysis revealed two D-Cys, one L-Ile, one D-Ile, and one L-Val 
residue. 
Table 3.3. 1H and TOCSY NMR analysis of malformins A1 (A) and B4 (C). Marfey’s HPLC analysis by 
retention time (RT) for malformins A1 (B) and B4 (D). 
 
 
 
Malformin D (3.25) was isolated (0.8 mg) as a white powder with the formula C23H39N5O5S2 
calculated from m/z 530.2465 (seven degrees of unsaturation) as determined by the HRESIMS 
[M + H]+ ion at m/z 530.2457. The 1H NMR data (Table 3.4) displayed typical characteristics of 
a pentapeptide with five amide NH signals (δH 8.90, 8.59, 7.92, 7.40, 7.15), five α-amino protons 
(δH 4.72, 4.44, 4.17, 3.96, 3.93), and five amide resonances (δC 173.9, 173.1, 173.0, 170.7, 
169.6) in the 13C spectrum, yet these values did not match any of the known malformins. 
Interpretation of 1H-1H COSY and TOCSY NMR spectra led to the identification of the five 
amino acids: two disulfide linked Cys, one Ile, one Leu, and one Val residue. The sequence of 
the amino acid residues was then established by NOESY correlations (Figure 3.10). A NOESY 
Standard'RT'(min)' Isolated'
Malformin'Amino'Acid' L8'Conformer' D8'Conformer'
Cys' 11.49' 11.92' 11.81'(x2)'
Ile' 21.61' 25.04' 21.54'
Leu' 21.89' 25.31' 25.47'
Val' 19.97' 23.28' 19.91'
malformin'A1'(3.23)'
'' 1H'TOCSY'(ppm)'
Amino'Acid' NH' CHC=O' Side'Chain'CorrelaQons'
Cys' 8.86' 3.99' 3.52'(CH2a),'3.17'(CH2b)'
Ile' 8.61' 3.88' 1.70'(CH),'1.55'(CH2a),'1.14'(CH2b)'
Val' 7.96' 3.93' 2.04'(CH)'
Leu' 7.39' 4.47' 1.78'(CH),'1.41'(CH2)'
Cys' 7.12' 4.72' 3.25'(CH)'
A B
Standard'RT'(min)' Isolated'
Malformin'Amino'Acid' L8'Conformer' D8'Conformer'
Cys' 11.49' 11.92' 11.84'(x2)'
Ile' 21.61' 25.04' 21.66,'25.11'
Leu' 21.89' 25.31' ND'
Val' 19.97' 23.28' 19.64'
malformin'B4'(3.24)'
'' 1H'TOCSY'(ppm)'
Amino'Acid' NH' CHC=O' Side'Chain'CorrelaQons'
Cys' 8.92' 4.00' 3.52'(CH2a),'3.12'(CH2b)'
Ile' 8.65' 3.89' 1.50'(CH)'
Val' 8.44' 3.97' 2.06'(CH)'
Ile' 7.15' 4.36' 1.55'(CH)'
Cys' 7.01' 4.71' 3.30'(CH2)'
C D
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cross-peak was established between NH Cys-1 (δH 8.90) and 
the α-proton of Leu-1 (δH 4.17). The NH of Cys-1 (δH 8.90) 
and the α-proton of Leu-1 (δH 4.17) both correlated to the 
carbonyl of Cys-1 (δC 173.1). The NH of Leu-1 (δH 8.59) 
showed a NOESY correlation to the α-proton of Leu-2 (δH 
4.44), along with the HMBC correlation of the NH of Leu-1 
(δH 8.59) and the α-proton of Leu-2 (δH 4.44) with the Leu-1 
carbonyl (δC 173.0). The Leu-2 NH (δH 7.40) was correlated to 
the α-proton of Val (δH 3.93) via NOESY. Their coupling was further confirmed by the HMBC 
correlation of Leu-2 NH (δH 7.40) and the α-proton of Val (δH 3.93) to the carbonyl of Leu-2 (δC 
170.6). The Val and Cys-2 residues were correlated by NOESY [Val NH (δH 7.92) to α-proton of 
Cys-2 (δH 3.96)] and HMBC [Val NH (δH 7.92) and α-proton of Cys-2 (δH 3.96) to Cys-2 
carbonyl (δC 173.9)]. Finally, the Cys-1 and Cys-2 connection was verified by HMBC [NH of 
Cys-2 (δH 7.15) and Cys-1 α-proton (4.74) to Cys-1 carbonyl (δC 173.1). This completes the 
cyclization of the five residues leaving one degree of unsaturation unfilled, but like all other 
malformin peptides a disulfide linkage exists between the two cysteine residues. This disulfide 
bridge brings the two amide protons of the cysteines into close proximity as evidenced by their 
NOESY correlation (δH 8.90 and 7.15 for Cys-1 and Cys-2, respectively). 
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Figure 3.10. Key NOESY 
correlations to establish amino 
acid sequence of 3.25 
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Table 3.4. 1H and TOCSY NMR analysis of malformin D (3.25). 
 
 
3.5 Upregulation of Secondary Metabolites in Co-culture 
In an effort to understand the metabolism of Bipolaris sp. and A. niger and whether these natural 
products were upregulated, the LCMS fingerprints between control and co-culture were 
compared. The three most abundant ions for each compound were extracted from the TIC and 
the peak areas for controls vs. co-culture were compared (Table 3.5). The results showed an 
upregulation of 19 and 9 times for 3.20 and 3.21, respectively, from Bipolaris. However, 3.22 
was not detected in the control experiment as it was produced de novo, likely in response to 
competitive interactions from A. niger. Interestingly, the total malformin concentration decreased 
by more than half despite their antibiotic properties.39 
Table 3.5. Peak areas from EIC for the bipolarolides and malformins from each of the extracted regions.  
 
 
Amino Acid δNH (J in Hz) δαH (J in Hz) TOCSY Side Chain Correlations- δH (J in Hz)
D-Cys-1 8.90, d (4.0) 3.96, m 3.51, 1H, dd (15.0, 4.0)
3.16, 1H, m
L-Leu-1 8.59, d (6.3) 4.17, ddd (9.0, 6.3, 6.3) 1.57, 1H, m
1.50, 1H, m
1.31, 1H, m
0.9, 3H, m
0.84, 3H, m
L-Val 7.92, d (8.5) 3.93, m 2.03, 1H, dq (8.0 , 5.5)
0.85, 6H, m
L-Leu-2 7.40, d (9.5) 4.44, td (9.5, 5.7) 1.58, 1H, m
1.41, 1H, m
1.32, 1H, m
0.88, 3H, m
0.86, 3H, m
D-Cys-2 7.15, d (11.0) 4.72, td (11.0, 4.2) 3.23, 2H, m
Compound(
bipolarolide(A((3.20)( bipolarolide(B((3.21)( bipolarolide(C((3.22)( All(malformins(
Bipolaris(control( 14779( 10135( ND( ND(
Bipolaris(co@culture( 276054( 89102( 20494( 58298(
A.+niger(control( ND( ND( ND( 289988(
A.+niger(co@culture( 31577( ND( 3057( 119364(
Zone(of(InhibiGon( ND( ND( ND( 28533(
UpregulaGon( 19( 9( De+novo+ 0.4(
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3.6 Conclusions and Future Work 
Co-culturing against A. niger has proven to upregulate the bipolarolides (3.20-3.22) from 
Bipolaris sp. and bipolarolide C was only produced in co-cultures. Competitive interactions seem 
to favor the biosynthetic production of these compounds which could mean they have 
antimicrobial properties, however, limited yields did not allow for bioassays against A. niger or 
other microorganisms. In fact, all of the bipolarolides and ascospiroketal A were isolated at <1 
mg and thwarted our attempts to assay for bioactivity. None of the alternariols displayed 
inhibition of A. niger in disk-diffusion assays. However, fractions from Bipolaris inhibited 
growth, meaning that a combination of compounds could have synergistic effects. All of the 
malformins showed minimal activity (8 mm zone with a 6 mm disk) against Candida albicans at 
50 µg. 
 
Some of the stereocenters of 3.20-3.22 remain unassigned; efforts are currently ongoing to grow 
crystals of sufficient quality for single crystal X-ray diffraction. Again, limited yields of these 
compounds are hampering attempts so other Bipolaris extracts are being worked up to isolate 
more of these compounds for crystallization methods and bioactivity studies. These initiatives 
will certainly unearth the relative configuration of these unique natural products and determine 
their role as defensive metabolites. 
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Chapter 4. Rapid Screening of a Miniaturized-microbial Library 
 
4.1 Natural Product Screening Background 
Natural product screening programs have been ostracized by many large pharmaceutical 
companies even though the importance of natural products is undeniable.1 Synthetic and 
combinatorial libraries have gained popularity but their structural motifs are repetitive and do not 
match the complexity offered by natural products.2 It is without question that big pharma targets 
drugs with monetary feedback; this leaves a niche to fill by smaller laboratories to develop 
antibacterial and NTD screening programs. Traditionally, these infectious diseases have been 
ignored due to short, inconsistent dosing periods and low monetary value in impoverished 
nations. But there are several reports of successful integration of high-throughput drug discovery 
employing natural product libraries.3-6 A previous screening project in our laboratory6 funded by 
MMV utilized microorganism metabolites in the hunt for new antimalarials. This project 
identified two lead compounds, trichothecinol D (4.1) and dicerandrol D (4.2), with nanomolar 
potency against Plasmodium falciparum and high selectivity indices.  
 
Microbial cultures have the advantage of being strictly controlled in the laboratory and their 
cultivation can be miniaturized to maximize resources. In addition, microbial natural products 
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are diverse and have broad-spectrum bioactivity and are especially viable as anti-infective 
agents.1,7 Collaborations were set up to screen crude extracts and fractions against methicillin-
resistant Staphylococcus aureus (MRSA) and the leishmaniasis-causing parasite Leishmania 
donovani. Our goal was to establish an efficient way to isolate, culture, fractionate, and screen a 
microbial library with the added objective of finding new bioactive natural products. 
 
4.2 Chemodiversity Lab Methodology 
Similar to the strategy implemented in the previous chapter, endophytes from Florida mangroves 
and endosymbiotic microbes from marine macroorganisms were the basis of the screening 
pipeline. Cultures were minimized to 50 mL of artificial salt water (ASW) supplemented SDB 
for fungi (or ASW-TSB for bacteria) in plastic syringes and two different extraction methods 
were explored, both within the culture tube. To expedite the extraction process, extraction resins 
were placed in teabags to soak in 21-day old cultures for targeted small molecule extraction. 
These compounds were absorbed overnight and the resin was rinsed with H2O to elute water-
based media components and extracted over 5 min with sonication in MeOH. A combination of 
XAD7 (polar, acrylic substrate) and HP20 (nonpolar, phenyl substrate) were used in a 1:1 ratio 
to extract a broad polarity range of compounds. The efficiency of this method was compared to 
the tried-and-true method of lyophilization, a time consuming process. Extraction methods were 
evaluated based on their LCMS and bioactivity profiles. The complex mixtures generated by 
natural product libraries can cause misleading and inconsistent results.8,9 To combat this a 
preparative LCMS fractionation step generated 12 fractions per extract and greatly reduced the 
media components and number of compounds per fraction. Rapid evaporation of this aqueous 
solvent in vacuo could be achieved via a temperature-controlled centrifugal evaporator. Avoiding 
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another tedious and time-consuming step, vials were not weighed but fraction concentrations (5 
mg/mL) were approximated in DMSO and sent off for bioactivity screening. 
 
This screening has adopted an OSMAC approach to increase the chemical potential of the 
microbial library with hopes of turning on cryptic natural product biosynthetic pathways using 
epigenetic modification. Secondary metabolism is regulated within the fungal genome and the 
discovery of the LaeA protein showed that transcription can be regulated within certain parts of 
the genome, like the chromatin-based regulation in Aspergillus spp.10 This prompted further 
investigations and it was hypothesized that gene clusters are conserved in all fungal species and 
HDACs, functionally similar to LaeA, can target secondary metabolite regulation.11 Small 
molecule inhibition of HDACs were confirmed to upregulate secondary metabolism in 
Aspergillus nidulans11 and Cladosporium cladosporiodes.12 Sodium butyrate (4.3) is a small 
molecule inhibitor of HDACs13,14 and was shown to produce the otherwise “silent” cytosporone 
R (4.4) from a Leucostoma persoonii fungus using 100 µM concentrations of 4.3.15 
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4.3 Results of Screening 
In total, 576 organisms (288 fungi and 288 bacteria) have been cultured resulting in 5760 
screened fractions. The fractionation and bioassay process is still ongoing; as a result, MRSA 
results are up to date while only 4608 fractions have been screened against L. donovani. In 
general, the differences of the two extraction methods (teabag resin vs. freeze drying) were 
minimal. The teabags were reused and the complete elution of all compounds from the resin was 
difficult, this cross contamination could have led to the small discrepancies observed. 
Unfortunately, the bioactivity data for the crude extracts and their resulting fractions is lacking 
so no conclusions can be drawn for the extract vs. fraction screening methodology. A similar 
screening project in our laboratory utilizes fungal extracts from rice media; this sister screening 
cultured 19 of the same fungi as the present study. From this sample size, seven of the 19 fungi 
displayed comparable bioactivity; this variance could be attributed to the different culture 
methods (liquid vs. solid) or due to lower concentrations of the unweighed fractions. The 
bioactivity for the two phenotypic screenings will now be described. 
 
4.3.1 MRSA Bioactivity 
Clinical infections of MRSA 
have become increasingly 
common and deadly, with 18650 
deaths in the US in 2005.16 The 
abuse of antibiotics has also 
enhanced resistance and new 
antibiotics are vital as we are 
Figure 4.1. Active breakdown of MRSA screening. 
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currently losing the battle to these pathogens! In the current screening, a hit rate of 0.7% was 
observed against a clinical isolate of MRSA (Figure 4.1). This hit rate is rather low especially 
considering that several fractions can hit from a single extract due to active compound “bleed” 
between neighboring fractions during chromatographic separation. Hits were only observed at 
the highest screening concentration (200 µg/mL) against the pathogen and no inhibition was 
noted below this threshold. The similar screening project using fungal extracts from rice 
(mentioned above) had a significantly higher hit rate; this could be due to low fraction 
concentrations since they were not measured. 
 
4.3.2 Leishmania donovani Bioactivity 
The significance of leishmaniasis has been described in Chapter 2, but this NTD remains a 
serious global health problem. This screening identified 92 fraction hits corresponding to a 1.9% 
hit rate against L. donovani axenic amastigotes (Figure 4.2). To further prioritize hits, 
cytotoxicity was tested against 
the J774 cell line and an infected 
macrophage that can project 
clinical efficacy since 
compounds must penetrate the 
macrophage in a human host.17 
Thirty-two fractions were chosen 
as primary interest having an  Figure 4.2. Active breakdown against L. donovani. 
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SI > 10 (cytotoxicity/axenic amastigote activity). Any hits were further tested against infected 
macrophages and two fractions in particular had impressive selectivity, EG09-09B-1 fraction 7, 
SI= 99.9 and MHP-6B-3 fraction 7, SI= 45.6, which warrant further investigation. 
 
4.4 Compound Isolation from Active Fractions 
It should be noted that identification of active components from these fractions was challenging 
considering the minute quantity of impure compounds (<100 µg for some fractions) remaining 
after fractionation of a 50 mL culture. But one fraction from a non-epigenetically modified 
fungus (EG09-09B-1 fraction 7, sample name R1-P2-7) was predominantly pure and the 
resulting HRESIMS (Figure 4.3, A) showed a definitive loss of acetate m/z 295.2055 [M-
HOAc]+ from the proton adduct at m/z 355.2263 [M+H]+ confirming an acetyl moiety within the 
structure; and a chemical formula of C23H30O3 was predicted from the calculated m/z 355.2268. 
Furthermore, 1H NMR spectral analysis (Figure 4.3, B) displayed the characteristic peaks [δH 
7.2, 1H, d (J= 10.2 Hz), δH 6.11, 1H, dd (J= 10.2 and 1.9 Hz), and δH 5.99, 1H, br t] associated 
with α, β-unsaturated ketones. Also evident was the presence of terminal alkene protons [δH 
5.79, 1H, ddd (J= 17.4, 10.4, and 1.6 Hz), δH 4.93, 1H, dd (J= 17.4 and 1.6 Hz), and δH 4.91, 
1H, dd (J= 10.4 and 1.6 Hz)].  
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Figure 4.3. HRESIMS (A) and 1H NMR (B) spectral analysis of 4.5. 
 
 
With these structural features and a chemical formula, a search of the AntiMarin database 
exposed one likely match, a pregnane steroid (4.5),18 which was confirmed through the 
remaining 1H NMR signals (Table 4.1). Unfortunately, the remaining material was not of 
sufficient quantity for optical rotation to establish stereochemistry, but ROESY analysis can give 
the relative configuration. The pregnane scaffold is common to sponges and corals but this 
compound was isolated from a mangrove fungus. Certainly, this is plausible as marine 
microorganisms inhabit a wide variety of substrates and endosymbiotic microbial origin of 
metabolites has been shown.19-21 
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Table 4.1. 1H NMR data comparison to literature18 value of 4.5. 
 
 
4.5 Conclusions and Future Work 
This screening program successfully initiated methodology for small-scale culturing, rapid 
extraction, and efficient generation of screenable fractions. The hit rates for each target (0.7% 
and 1.9%, respectively) were low, but fall generally within acceptable ranges in natural product 
screening programs.22 Epigenetically unmodified fungi had a greater number of total active 
fractions (119 control vs. 82 HDAC modified). The chemodiversity within the library seemed to 
vary as nearly all fractions hit (1-12, corresponding to compound polarity) and only a few 
nuisance compounds were seen in multiple active fractions. Finally, a pregnane steroid (4.5) was 
C"H$ Literature$δH$(CDCl3)$ δH$4.5$(d6"DMSO)$
1$ 7.03,$d$(10.2)$ 7.2,$d$(10.2)$
2$ 6.23,$dd$(10.2,$1.9)$ 6.11,$dd$(10.2,$1.9)$
3$ $
4$ 6.07,$br$t$ 5.99,$br$t$
5$ $
6$ 2.46,$m$ 2.37,$m$
$ 2.36,$ddd$(13.3,$4.1,$2.5)$
7$ 1.98,$m$ 1.91,$m$
$ 1.08,$m$ 1.06,$m$
8$ 1.73,$m$ 1.73,$m$
9$ 1.12,$m$ 1.14,$m$
10$ $
11$ 1.78,$m$ 1.77,$m$
$ 1.58,$m$ 1.56,$m$
12$ 2.17,$m$ 2.07,$m$
$ 0.98,$m$ 0.97,$m$
13$ $
14$ 1.28,$m$ 1.28,$m$
15$ 1.89,$m$ 1.91,$m$
$ 1.26,$m$ 1.24,$m$
16$ 1.9,$m$ 1.9,$m$
$ 1.73,$m$ 1.73,$m$
17$ 2.08,$m$ 2.05,$m$
18$ 4.07,$bq$(11.8)$ 4.02,$bq$(11.8)$
19$ 1.24,$s$ 1.2,$s$
20$ 5.8,$ddd$(17.2,$10.2,$7.7)$ 5.79,$ddd$(17.4,$10.4,$7.5)$
21$ 4.96,$dd$(17.2,$1.6)$ 4.93,$dd$(17.4,$1.6)$
$ 4.93,$dd$(10.2,$1.6)$ 4.91,$dd$(10.4,$1.6)$
COCH3$ 2.05,$s$ 1.99,$s$
O
O
O
1
4
19
8
14
12
18
17
21
4.5
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isolated as the major compound from a fraction with axenic amastigote activity of 2.0 µg/mL and 
no cytotoxicity below 50 µg/mL. The IC50 activity against infected macrophages was determined 
to be 0.5 µg/mL, this affords an SI of 25.2 and 99.9 for axenic amastigote and infected 
macrophages, respectively. This demonstrates that compound dereplication from this 
miniaturized setup is possible. 
 
There is still a significant portion of samples that need to be screened in both assays and data 
corresponding to the crude extracts has been delayed at the current time. These remaining 
samples should be screened so that an equal number of bacteria and fungi are analyzed. Further 
work needs to be done to establish the stereochemistry of 4.5, and several active fractions 
contained a similar compound (retention time= 4.5 min, m/z 320.2970) that needs to be 
dereplicated to alleviate its recurring isolation during bioassay-guided fractionation. 
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Chapter 5. Experimental 
 
5.1 General Procedures 
HPLC was performed on a Shimadzu LC20-AT equipped with photodiode array (M20A) and 
evaporative light scattering (LT-II) detection using semi-preparative [Phenomenex Luna C18 
(250 x 10 mm, 5 µm) and Phenomenex Luna Silica (250 x 10 mm, 5 µm)] or analytical 
[Phenomenex Luna C18 (250 x 4.6 mm, 5 µm) and Phenomenex Luna Silica (250 x 4.6 mm, 5 
µm)] conditions. Preparative LCMS was performed on an Agilent 1200 equipped with a 6120 
single quadrupole detector and a 1260 Infinity Preparative Scale Fraction Collector. Preparative 
chromatography was achieved on a C18 (25 x 100 mm) Waters PREPLC Module. Analytical 
LCMS was performed on a Phenomenex Kinetex C18 column (50 x 2.1 mm, 2.6 µm) on either 
an Agilent 6120 single quadrupole or an Agilent 6540 LC/QToF-MS with ESI detection. MPLC 
was performed on a Teledyne Isco CombiFlash Companion using 330 g silica cartridges. Optical 
rotations were measured on a Rudolph Research Analytical AUTOPOL IV digital polarimeter. 
Other spectroscopic data was collected on an Agilent Cary 630 FTIR or Cary 60 UV-Vis 
spectrometer. 1H NMR spectra were recorded on a Varian 500 or 600 MHz direct-drive 
instrument equipped with cold-probe detection; 13C NMR spectra were recorded at 150 MHz. 1H 
and 13C residual solvent were referenced as internal standards, and all shifts are measured in ppm 
and coupling constants in Hz. 
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5.2 Experimental Supporting Chapter 2 
5.2.1 Collection of Biological Materials 
Four sampling sites were chosen within a 3.5 km boating radius from Palmer Station in the 
austral summer of 2011, including 1) Norsel Point (64°45.674’S, 64°05.467’W); 2) Bonaparte 
Point (64°46.748’S, 64°02.542’W); 3) Gamage Point (64°46.345’S 64°02.915’W); and 4) 
Laggard Island (64°48.568’S, 64 00.984’W) (Figure 2.3). 
 
Twenty sponge specimens including associated amphipods were collected via SCUBA from 
March and April 2011. Specimens were taken in triplicate from both habitats from each site 
except site 4, from which only one specimen from each habitat was collected. Finely sewn mesh 
collecting bags were used to capture amphipods associated with each specimen. Larger 
amphipod species were separated into designated bins from individual sponges by gentle 
agitation. Amphipods hiding within sponge pores and canals, i.e. Colomastix fissilingua, were 
quantified under the microscope. Amphipod and algal identification was based on the methods of 
our previous studies of the local taxa and identification was done by von Salm J. S. and Amsler 
M. O. Amphipods were identified to species where possible although in one case (Oedicerotidae) 
only the family level was possible. Additional bulk D. membranosa samples were collected to 
produce chemical standards in support of quantification in study specimens. Sponge samples 
were frozen and transported back to the University of South Florida at -70°C where tissues were 
lyophilized and stored at -80°C until further processing.  
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5.2.2 Isolation of Natural Products from D. membranosa 
From the 2011 bulk collection, 25.7 g of freeze-dried D. membranosa was extracted with 
dichloromethane and concentrated in vacuo. The lipophilic extract (994 mg) was absorbed onto 
Waters Sep-Pak® C18 cartridges and eluted with acetonitrile. The dried material (205 mg) was 
separated by isocratic semi-preparative HPLC (C18) using 60% acetonitrile in water to afford 
aplysulphurin (10.2 mg), tetrahydroaplysulphurin (1.5 mg) and membranolide A (8.7 mg). 
 
5.2.3 Metabolomic Analysis of D. membranosa 
Following a similar procedure to that used for the isolation of natural product standards, study 
specimens were extracted with dichloromethane and subjected to C18 solid phase extraction. The 
eluate was dried in vacuo then resuspended at 1.0 mg/mL in acetonitrile for analysis by 
LC/QToF-MS in positive mode. Separation was achieved using water with 0.1% formic acid as 
mobile phase (A) and acetonitrile with 0.1% formic acid as mobile phase (B). A binary gradient 
was employed ramping from 40-60% (B) over 3 minutes, 60% (B) isocratic for 4 minutes, 
increased to 60-100% (B) over 3 minutes, and finally held at 100% (B) for 2 minutes. The source 
was maintained at 300 °C and a capillary voltage of 3500 V. Nitrogen was used as the drying gas 
(8 L/min) and sheath gas (11 L/min) at a temperature of 300 °C and 350 °C, respectively. 
Aplysulphurin, tetrahydroaplysulphurin and membranolide A were quantified as external 
standards with concentration curves (R2 > 0.97). All samples were analyzed in triplicate with 
injection volumes of 2 µL. 
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5.2.4 Statistical Analysis of Metabolomic Fingerprinting 
The top 100 compounds as determined by peak area (including known secondary metabolites) in 
each sponge extract were extracted from the total ion chromatogram by molecular feature using 
MassHunter Qualitative Analysis 5.0. Mass Profiler Professional 11.0 was used to classify 
entities by interpretation and each entity was normalized to the crude extract mass. Blanks 
consisting of dried dichloromethane residue and acetonitrile were used to subtract solvent 
impurities from sample peaks. Compounds that were present in two of three replicates were 
included in the final entity list. 
 
The following statistical analysis was performed by von Salm J. L., entity lists for each sample 
were square root transformed along with the amphipod abundance numbers, which were 
standardized to sponge displacement in seawater. An S17 Bray-Curtis resemblance matrix was 
created for the top 100 compounds. ANOSIM and SIMPER analyses were employed to test for 
significance of habitat, site, or amphipod density on metabolomic data. Amphipod counts 
included only those amphipods that were deemed to be omnivorous and, therefore, potential 
predators as well as those shown to be statistically correlated to the chemical entity data as per 
the BIOENV procedure as part of the BEST routine. 2D MDS was plotted from dendrogram and 
the amphipod counts were overlaid directly as 2D bubbled factors. 
 
5.2.5 Initial Study of Methanolic Degradation of Aplysulphurin 
Aplysulphurin was diluted to 1 mg/mL in MeOH and aliquots (10 µL) were taken initially then 
every three hours and placed into LCMS vials where N2 was used to dry off residual solvent; 
then diluted to 1 mL with ACN.  Sample analysis was performed via LC/QToF-MS with a 
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gradient of 40-60% ACN in H2O (0.1% FA) over 7 minutes to monitor prepared samples. The 
same studies were performed with EtOH using 0.1% AcOH or pyridine to visualize ethoxy 
artifacts. 
 
5.2.6 Isolation of Methoxy-substituted Membranolides 
24 mg of aplysulphurin was dissolved in MeOH and allowed to react for 48 hours. Semi-
preparative HPLC (C18) was employed with a 60-65% ACN in H2O linear gradient over 30 min 
and subsequent analytical HPLC (silica) with 10-100% EtOAc in hexane. Yields were as 
follows: membranolide B (2.11), 5.0 mg (20.8%), membranolide C (2.12) 1.0 mg (4.2%), 
membranolide D (2.13) 0.3 mg (1.3%), membranolide E (2.19) 0.2 mg (0.8%), membranolide F 
(2.20) 0.5 mg (2.1%), membranolide G (2.21) 0.9 mg (3.8%), and membranolide H (2.22) 0.7 
mg (2.9%). 
 
5.3 Experimental Supporting Chapter 3 
5.3.1 Fungal Material  
A small piece of the sponge Xestospongia muta was surface sterilized with 70% IPA for 30 s and 
rinsed with sterile water. Small pieces of the sponge were transferred aseptically onto isolation 
plates of ACT agar (5 g glycerol, 4 g of sodium propionate, 2 g of sodium caseinate, 0.5 g of 
dipotassium phosphate, 0.1 g of asparagine, 0.1 g of magnesium sulfate, 1 mg of ferrous sulfate, 
and 15 g of agar per liter). Fungal colonies were allowed to grow and were isolated on SDA (40 
g dextrose, 10 g of mycological peptone, and 15 g agar per liter pH= 5.6). After isolation, the 
fungal strain Bipolaris sp. was subjected to 18S ribosomal RNA sequencing and provided a 99% 
!! 90!
match against Bipolaris for both the forward and reverse primers. Aspergillus niger was 
purchased from Presque Isle Cultures (Erie, PA) and maintained on SDA. 
 
5.3.2 Cultivation 
Small plugs (~1 cm) of Bipolaris sp. were inoculated onto 136 SDA plates (95 x 15 mm) and 
allowed to incubate at room temperature for three days. On the third day, plugs of A. niger were 
inoculated onto the same plates initiating the co-culture; these plates were allowed to incubate at 
room temperature for an additional 18 days. In efforts to maximize the interactions between the 
fungi two plugs of each fungus were plated resulting in two clear zones of inhibition. In a 
parallel study, 31 control plates of either fungus (2 plugs per plate) were incubated at room 
temperature for 21 days. 
 
5.3.3 Isolation of Metabolites 
The methanolic extract of co-cultured Bipolaris sp. (6.24 g) was partitioned between EtOAc and 
H2O to yield 1.37 g of the organic soluble fraction. This fraction was subjected to MPLC with a 
linear gradient from Hex to EtOAc to 20% MeOH in EtOAc yielded eight fractions. The fraction 
eluting at roughly 50% Hex/EtOAc was purified by semi-preparative HPLC (Si) consisting of a 
10-100% EtOAc in hexane gradient for 45 min to yield 13 fractions. Fraction K yielded 
bipolarolide B (3.21) 0.8 mg (0.013%) after analytical HPLC (C18) with a 10-100% ACN in 
H2O over 30 min. From the NP MPLC, the fraction eluting at 100% EtOAc (174 mg) underwent 
semi-preparative HPLC (C18) employing a 30-35% ACN in H2O over 60 min yielding 14 
fractions. Fraction F (3.8 mg) was further purified using analytical HPLC (C18) with a 20% 
isocratic ACN in H2O solvent system to yield bipolarolide A (3.20) 0.4 mg (0.0064%). 
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Bipolarolide C (3.22) 0.5 mg (0.0081%) was obtained from fraction N (3.2 mg) of the semi-
preparative HPLC (C18) fractionation listed above after a 40-60% gradient using ACN in H2O. 
 
The co-cultured A. niger MeOH extract (2.49 g) was partitioned between EtOAc and H2O to 
yield 667 mg of the organic soluble material. This organic extract was subjected to MPLC with a 
hexane to EtOAc to 20% MeOH gradient to give 11 fractions. Fractions 7 (27.3 mg) and 8 (21.3 
mg), eluting at 80% EtOAc/hexane were combined with analogous NMR spectra and were 
further purified on semi-preparative HPLC (C18) with a 10-100% ACN gradient to yield 14 
fractions. Malformin D (3.25) 0.8 mg (0.032%) was obtained from fraction G using 40% 
isocratic ACN in H2O. Fraction F underwent analytical HPLC (C18) using 40% isocractic ACN 
in H2O to yield malformins A1 (3.23) 1.2 mg (0.048%) and B4 (3.22) 1.1 mg (0.044%). 
 
Bipolarolide A (3.20) White gum; [α]20 D -120.6 (c= 0.1, CHCl3); UV-Vis (MeOH) λmax (ε): 232 
nm; IR (thin film) 3275 (br), 2921, 2854, 1730, 1570, 1514, 1413, 1253, 1089 cm-1; for 1H and 
13C NMR please refer to Table 3.1; HRESIMS m/z [M+H]+ 297.1701 (calculated for C16H24O5 
297.1697). 
 
Bipolarolide B (3.21) White gum; [α]20 D -70.3 (c= 0.1, CHCl3); UV-Vis (MeOH) λmax (ε): 239 
nm; IR (thin film) 2929, 2873, 1737, 1722, 1514, 1461, 1434, 1082 cm-1; for 1H and 13C NMR 
please refer to Table 3.1; HRESIMS m/z [M+H]+ 339.1796 (calculated for C18H26O6 339.1802). 
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Bipolarolide C (3.22) White powder; [α]20 D -30.1 (c= 0.1, CHCl3); UV-Vis (MeOH) λmax(ε): 
258 nm; IR (thin film) 3368 (br), 2929, 2862, 1722, 1461, 1271, 1160 cm-1; for 1H and 13C NMR 
please refer to Table 3.2; HRESIMS m/z [M+H]+ 349.1953 (calculated for C18H30O5 349.1985). 
 
Malformin D (3.25) White gum; [α]20 D +50.2 (c= 0.1, DMSO); UV-Vis (MeOH) λmax (ε): 265, 
285 nm; IR 2959, 2929, 2873, 1737, 1659, 1540, 1264 cm-1; for 1H and 13C NMR please refer to 
Table 3.4; HRESIMS m/z [M+H]+ 530.2460 (calculated for C23H39N5O5S2 530.2465). 
 
5.3.4 Stereochemical Determination of L-FDVA Derived Amino Acids 
Amino acids were subjected to nucleophilic aromatic substitution with 1-fluoro-2,4-
dinitrophenyl-5-L-valine amide (L-FDVA), resulting in diastereomeric products that can be 
separated by analytical HPLC (C18) with H2O-TFA 0.1% and ACN mobile phase. Each peptide 
(200 µg) was oxidized with performic acid (9:1 formic acid: 30% H2O2 at rt for 1 hr) for 3 hrs at 
5°C. The solvent was dried in vacuo and hydrolyzed with 6 N HCl (1 mL) at 110°C for 24 hrs 
before the solvent was dried under a stream of N2. The resulting material was dissolved in H2O 
(100 µL) with 1 N NaHCO3 (20 µL) before the addition of L-FDVA in acetone (10 mg/mL, 100 
µL). The reaction was heated to 35°C for 1 hr, before being quenched with 2 N HCl (10 µL), and 
diluted with ACN (1 mL) before HPLC-MS analysis. 
 
A gradient was optimized utilizing a H2O (0.01% TFA) and ACN solvent system. Initially, 5% 
ACN in H2O (0.1% TFA) was run for 5 min, followed by a ramp up to 40% ACN for 20 min, 
then finally up to 100% ACN for 5 min. The retention times for the standard amino acid/FDVA 
derivatized compounds are as follows: 11.49 min and 11.92 min, respectively for L- and D- 
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cysteic acid; 19.97 min and 23.28 min, respectively for L- and D-Val; 21.61 min and 25.04 min, 
respectively for L- and D- Ile; and 21.89 min and 25.31 min, respectively for L- and D-Leu. 
Malformin A1 (3.23) displayed peaks at 11.81 min (x2), 19.91 min, 21.54 min, and 25.47 min 
corresponding to D-Cys (x2), L-Val, L-Ile, and D-Leu amino acids. Malformin B4 (3.24) 
displayed peaks at 11.84 min (x2), 19.64 min, 21.66 min, and 25.11 min corresponding to D-Cys 
(x2), L-Val, L-Ile, and D-Ile amino acids. Malformin D (3.25) again displayed the two typical D-
Cys peaks at 11.78 min, L-Val at 19.74 min, L-Ile at 21.69 min, and L-Ile at 21.95 miin. 
 
5.3.5 Analysis of the Metabolite Regulation 
Crude samples of each experiment were concentrated to 1.0 mg/mL and analyzed via LC/QToF-
MS using a 10-100% ACN in H2O (0.1% FA) with 2 µL injection volume. The new compounds 
bipolarolide A (3.20), bipolarolide B (3.21), bipolarolide C (3.22), and malformins (3.23-3.25) 
were analyzed as standards and the three highest abundance ions were used to generate an 
extracted ion chromatogram (EIC). The EIC peak areas were determined via MassHunter 
Qualitative Analysis 5.0 and averaged over three injections; baseline resolution of the 
malformins could not be achieved so the entire peak area was integrated. Upregulation was 
measured as the average peak area of the co-culture experiment divided by the control 
experiment. Please see Table 3.5 for these peak areas. 
 
5.3.6 Kirby-Bauer Disk Diffusion Assays 
Samples were dissolved in solvent and transferred aseptically onto sterile cotton disks (6 mm). 
The microorganism to bioassay against was inoculated as a lawn onto either SDA or TSA. Once 
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dry, the sample disks were placed onto the Petri dish and incubated overnight at 37°C to 
visualize the appearance of zones of inhibition. 
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5.4 Experimental Supporting Chapter 4 
5.4.1 Hits Against MRSA at 200 µg/mL 
 
 
 
 
 
Fraction Organism Bacteria/or/Fungus Teabag? Modified?
R1#P7#F7 EG09#07C#2 Fungus No N/A
R1#P7#G7 EG09#06B#1 Fungus No N/A
R1#P7#G8 EG09#06B#1 Fungus No N/A
R1#P8#E6 BG09#71B#B1#2 Fungus No N/A
R1#P9#C12 EG10#46C#3 Fungus No N/A
R2#P1#F5 KML12#S1#D#4#B Bacteria Yes N/A
R2#P6#B5 KML12#38MA#F1.1 Bacteria Yes N/A
R2#P6#D5 KML12#38MA#F#1.3 Bacteria Yes N/A
R2#P6#E5 KML12#44MA#A1 Bacteria Yes N/A
R2#P7#C5 EG10#51B#1B Bacteria No N/A
R2#P7#D5 EG12#3D#1 Bacteria No N/A
R2#P8#G5 KML12#S5#G1 Bacteria No N/A
R2#P9#A5 KML12#S5#D2.1 Bacteria No N/A
R2#P9#F5 KML12#S7#D2#B Bacteria No N/A
R2#P11#B5 KML12#42MG#D1.3 Bacteria No N/A
R3#P3#A5 CC08#01D#1 Fungus Yes Modified
R3#P3#B5 CC08#01D#1 Fungus Yes Unmodified
R3#P5#A5 EG12#44E#2 Fungus Yes Modified
R3#P5#D5 KML12#S1#D1#WC#D1.4 Fungus Yes Unmodified
R3#P5#G5 EG12#12B#2 Fungus Yes Modified
R3#P6#A6 EG12#12B#2 Fungus Yes Unmodified
R3#P6#B6 EG12#52E#3 Fungus Yes Modified
R3#P6#D5 KML12#3D#2 Fungus Yes Modified
R3#P6#E2 KML12#3D#2 Fungus Yes Unmodified
R3#P6#E3 KML12#3D#2 Fungus Yes Unmodified
R3#P6#E4 KML12#3D#2 Fungus Yes Unmodified
R3#P6#F9 EG12#59A#1 Fungus Yes Modified
R3#P6#F10 EG12#59A#1 Fungus Yes Modified
R3#P6#F11 EG12#59A#1 Fungus Yes Modified
R3#P6#F12 EG12#59A#1 Fungus Yes Modified
R3#P6#G8 EG12#59A#1 Fungus Yes Unmodified
R3#P6#G9 EG12#59A#1 Fungus Yes Unmodified
R3#P6#G10 EG12#59A#1 Fungus Yes Unmodified
R3#P6#G11 EG12#59A#1 Fungus Yes Unmodified
R3#P6#G12 EG12#59A#1 Fungus Yes Unmodified
R3#P8#G5 BG09#07B#4 Fungus No Unmodified
R3#P9#F5 BG09#25B#2 Fungus No Unmodified
R3#P10#F2 KML12#44MA#C1.1 Fungus No Modified
R3#P10#G5 KML12#44MA#C1.1 Fungus No Unmodified
Rack/1
Rack/2
Rack/3
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5.4.2 Hits Against L. donovani 
Hits are colored into axenic amastigote (yellow) or cytotoxicity (orange), and those with a SI >10 
(red). ND= Not determined. 
 
Sample'Position Axenic'amastigote'IC50(μg/ml) Cytotox'(J774)I'C50(μg/ml) Infected'Mac'IC50(μg/ml) AA'selectivity'Index IM'selectivity'Index
R1DP12'B7 6.186 24.558 >20 4.0 Inactive
R1DP12'B8 4.847 20.834 2.624 4.3 7.9
R1DP12'C3 3.614 15.093 >20 4.2 Inactive
R1DP12'D7 4.214 23.997 7.114 5.7 3.4
R1DP12'E8 5.149 18.214 >20 3.5 Inactive
R1DP12'E9 4.416 22.207 7.118 5.0 3.1
R1DP12'E10 4.358 17.311 9.385 4.0 1.8
R1DP12'E11 6.514 13.756 3.608 2.1 3.8
R1DP1'C7 2.807 25.398 0.5566 9.0 45.6
R1DP1'G6 7.182 24.815 7.077 3.5 3.5
R1DP2'A7 5.902 50 7.427 8.5 6.7
R1DP2'C7 1.984 50 0.5004 25.2 99.9
R1DP3'C7 3.98 50 >20 12.6 Inactive
R1DP5'G5 6.205 17.088 7.087 2.8 2.4
R1DP5'G7 6.053 15.892 >20 2.6 Inactive
R1DP5'G9 4.497 26.217 >20 5.8 Inactive
R1DP6'A4 6.059 15.601 1.748 2.6 8.9
R1DP7'A8 5.617 14.132 2.024 2.5 7.0
R1DP8'A11 2.532 50 >20 19.7 Inactive
R1DP8'C12 5.742 50 >20 8.7 Inactive
R1DP8'D3 2.955 50 9.704 16.9 5.2
R1DP8'D4 3.434 50 10.14 14.6 4.9
R1DP9'B7 5.222 50 >20 9.6 Inactive
R1DP9'C9 7.553 3.157 NA 0.4 Inactive
R1DP9'D11 5.732 26.724 10.14 4.7 2.6
R1DP9'F3 2.62 24.373 5.276 9.3 4.6
R1DP9'G3 3.532 37.358 >20 10.6 Inactive
R1DP10'A9 >20 19.637 7.117 1.0 2.8
R1DP10'B3 1.847 19.947 3.467 10.8 5.8
R1DP10'B4 0.826 17.843 2.471 21.6 7.2
R1DP10'E3 5.719 50 4.855 8.7 10.3
R1DP10'E4 4.772 20.095 1.176 4.2 17.1
R1DP10'G3 3.864 21.191 1.325 5.5 16.0
R1DP10'G4 2.034 31.375 2.692 15.4 11.7
R2DP5'C5 4.354 8.086 7.136 1.9 1.1
R2DP5'D5 2.901 1.582 3.447 0.5 0.5
R2DP5'E5 4.425 10.985 9.477 2.5 1.2
R2DP5'F5 4.661 16.825 17.42 3.6 1.0
R2DP6'C5 2.381 12.131 4.686 5.1 2.6
R2DP6'D5 3.084 6.891 9.856 2.2 0.7
R2DP6'E5 3.393 7.829 8.913 2.3 0.9
R2DP6'G6 2.156 11.743 >20 5.4 Inactive
R2DP9'A2 4.677 26.535 4.969 5.7 5.3
R2DP10'D3 7.457 24.704 >20 3.3 Inactive
R2DP11'B5 3.021 14.887 >20 4.9 Inactive
R2DP11'B12 5.741 16.407 >20 2.9 Inactive
R2DP11'G1' >20 17.892 10.6 0.9 1.7
R2DP11'G5 3.917 17.327 ND 4.4 ND
R3DP8'E9 16.23 50 ND 3.1 ND
R3DP8'E10 15.86 40.188 ND 2.5 ND
R3DP8'F9 17.63 35.639 ND 2.0 ND
R3DP8'F10 14.76 35.684 ND 2.4 ND
R3DP8'G10 15.31 31.055 ND 2.0 ND
R3DP9'A8 17.79 50 ND 2.8 ND
R3DP9'B8 15.64 50 ND 3.2 ND
R3DP9'G9 0.63 32.304 ND 51.3 ND
R3DP10'A9 14.77 22.498 ND 1.5 ND
R3DP10'B10 13.21 23.571 ND 1.8 ND
R3DP10'C10 10.63 25.728 ND 2.4 ND
R4DP1'A8 12.67 20.742 ND 1.6 ND
R4DP1'A9 11.9 11.845 ND 1.0 ND
R4DP1'A10 11.55 18.344 ND 1.6 ND
R4DP1'A11 17.06 32.664 ND 1.9 ND
R4DP1'B8 19.12 43.26 ND 2.3 ND
R4DP1'B9 15.72 43.451 ND 2.8 ND
R4DP1'B10 13.99 41.405 ND 3.0 ND
R4DP1'C8 16.54 29.761 ND 1.8 ND
R4DP1'C9 17.07 23.943 ND 1.4 ND
R4DP1'C10 13.89 23.769 ND 1.7 ND
R4DP1'D8 12.39 50 ND 4.0 ND
R4DP1'D9 3.47 30.628 ND 8.8 ND
R4DP1'D10 17.07 25.69 ND 1.5 ND
R4DP1'E9 18.28 41.918 ND 2.3 ND
R4DP2'B10 12.43 50 ND 4.0 ND
R4DP2'E9 12.83 50 ND 3.9 ND
R4DP2'G10 16.29 50 ND 3.1 ND
R4DP6'A3 9.54 50 ND 5.2 ND
R4DP6'A4 11.098 50 ND 4.5 ND
R4DP6'A5 10.131 39.305 ND 3.9 ND
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Sample'Position Axenic'amastigote'IC50(μg/ml) Cytotox'(J774)I'C50(μg/ml) Infected'Mac'IC50(μg/ml) AA'selectivity'Index IM'selectivity'Index
R4CP6'A6 6.03 50 ND 8.3 ND
R4CP6'A7 1.398 50 ND 35.8 ND
R4CP6'A8 2.665 50 ND 18.8 ND
R4CP6'A10 5.193 50 ND 9.6 ND
R4CP6'A11 6.208 50 ND 8.1 ND
R4CP6'A12 7.088 50 ND 7.1 ND
R4CP6'B1 3.044 50 ND 16.4 ND
R4CP6'B2 1.982 50 ND 25.2 ND
R4CP6'B3 4.329 50 ND 11.6 ND
R4CP6'B4 5.74 50 ND 8.7 ND
R4CP6'B5 5.381 50 ND 9.3 ND
R4CP6'B6 5.112 50 ND 9.8 ND
R4CP6'B7 5.704 50 ND 8.8 ND
R4CP6'B8 5.854 50 ND 8.5 ND
R4CP6'B9 6.352 50 ND 7.9 ND
R4CP6'B10 7.859 50 ND 6.4 ND
R4CP6'B11 7.422 50 ND 6.7 ND
R4CP6'B12 4.994 50 ND 10.0 ND
R4CP6'C1 9.552 50 ND 5.2 ND
R4CP6'C2 13.158 50 ND 3.8 ND
R4CP6'C3 4.758 50 ND 10.5 ND
R4CP6'C4 2.199 50 ND 22.7 ND
R4CP6'C7 7.071 50 ND 7.1 ND
R4CP6'C8 7.462 50 ND 6.7 ND
R4CP6'C9 7.65 50 ND 6.5 ND
R4CP6'C10 3.633 50 ND 13.8 ND
R4CP6'C11 8.868 50 ND 5.6 ND
R4CP6'C12 9.311 50 ND 5.4 ND
R4CP6'D1 2.607 50 ND 19.2 ND
R4CP6'D2 3.857 50 ND 13.0 ND
R4CP6'D3 11.864 50 ND 4.2 ND
R4CP6'D4 10.408 50 ND 4.8 ND
R4CP6'D5 6.677 50 ND 7.5 ND
R4CP6'D6 4.618 50 ND 10.8 ND
R4CP6'D9 7.325 50 ND 6.8 ND
R4CP6'D10 9.797 50 ND 5.1 ND
R4CP6'D11 9.322 50 ND 5.4 ND
R4CP6'D12 4.702 50 ND 10.6 ND
R4CP6'E2 11.788 50 ND 4.2 ND
R4CP6'E3 12.474 50 ND 4.0 ND
R4CP6'E4 12.126 50 ND 4.1 ND
R4CP6'E5 7.048 41.762 ND 5.9 ND
R4CP6'E6 8.139 50 ND 6.1 ND
R4CP6'E7 9.057 50 ND 5.5 ND
R4CP6'E8 4.388 50 ND 11.4 ND
R4CP6'E9 10.177 50 ND 4.9 ND
R4CP6'E10 11.003 50 ND 4.5 ND
R4CP6'E11 11.539 50 ND 4.3 ND
R4CP6'E12 5.776 50 ND 8.7 ND
R4CP6'F2 6.511 50 ND 7.7 ND
R4CP6'F3 5.828 50 ND 8.6 ND
R4CP6'F4 5.485 50 ND 9.1 ND
R4CP6'F5 6.267 50 ND 8.0 ND
R4CP6'F6 7.167 50 ND 7.0 ND
R4CP6'F7 6.766 50 ND 7.4 ND
R4CP6'F8 1.305 50 ND 38.3 ND
R4CP6'F9 6.993 50 ND 7.2 ND
R4CP6'F10 9.313 50 ND 5.4 ND
R4CP6'F12 5.198 50 ND 9.6 ND
R4CP6'G2 4.425 50 ND 11.3 ND
R4CP6'G3 3.038 50 ND 16.5 ND
R4CP6'G5 5.25 50 ND 9.5 ND
R4CP6'G6 6.361 50 ND 7.9 ND
R4CP6'G7 6.555 50 ND 7.6 ND
R4CP6'G8 5.789 50 ND 8.6 ND
R4CP6'G9 6.135 48.567 ND 7.9 ND
R4CP6'G10 11.602 50 ND 4.3 ND
R4CP6'G11 8.38 50 ND 6.0 ND
R4CP6'G12 4.504 50 ND 11.1 ND
R4CP7'A6 12.313 50 ND 4.1 ND
R4CP7'A7 3.676 38.405 ND 10.4 ND
R4CP7'A8 5.021 32.305 ND 6.4 ND
R4CP7'A9 6.021 32.33 ND 5.4 ND
R4CP7'A10 4.222 50 ND 11.8 ND
R4CP7'A11 2.081 50 ND 24.0 ND
R4CP7'A12 10.947 50 ND 4.6 ND
R4CP7CB1 12.422 50 ND 4.0 ND
R4CP7CB2 5.985 50 ND 8.4 ND
R4CP7CB3 6.872 50 ND 7.3 ND
R4CP7CB4 5.201 50 ND 9.6 ND
R4CP7CB5 2.294 50 ND 21.8 ND
R4CP7CB6 8.865 50 ND 5.6 ND
R4CP7CB7 11.509 50 ND 4.3 ND
R4CP7CB8 10.34 50 ND 4.8 ND
R4CP7CB9 5.41 50 ND 9.2 ND
R4CP7CB10 15.861 50 ND 3.2 ND
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5.4.3 LCMS Analysis of Active Fractions 
Once a hit was established the fraction underwent analysis by LC/QToF-MS to dereplicate 
samples. The residual DMSO was dried under a stream of nitrogen and concentrated to 0.1 
mg/mL in MeOH prior to injection into a 10-100% ACN in H2O gradient over 10 minutes. 
Compounds were evaluated upon their retention time and HRESIMS. 
Sample'Position Axenic'amastigote'IC50(μg/ml) Cytotox'(J774)I'C50(μg/ml) Infected'Mac'IC50(μg/ml) AA'selectivity'Index IM'selectivity'Index
R4CP7'C8 13.702 50 ND 3.6 ND
R4CP7'C9 17.383 50 ND 2.9 ND
R4CP7'C11 9.95 50 ND 5.0 ND
R4CP7'D3 11.515 50 ND 4.3 ND
R4CP7'D5 14.276 50 ND 3.5 ND
R4CP7'D6 8.395 50 ND 6.0 ND
R4CP7'E5 14.077 50 ND 3.6 ND
R4CP7'E6 15.524 50 ND 3.2 ND
R4CP7'E7 13.542 50 ND 3.7 ND
R4CP7'E8 5.193 33.493 ND 6.4 ND
R4CP7'E12 11.679 50 ND 4.3 ND
R4CP7'F1 18.065 50 ND 2.8 ND
R4CP7'F2 17.863 50 ND 2.8 ND
R4CP7'F3 4.261 50 ND 11.7 ND
R4CP7'G5 6.064 50 ND 8.2 ND
R4CP7'G6 18.094 50 ND 2.8 ND
R4CP7'G7 16.315 50 ND 3.1 ND
R4CP7'G8 16.001 50 ND 3.1 ND
R4CP7'G9 6.733 50 ND 7.4 ND
R4CP7'G10 12.022 50 ND 4.2 ND
R4CP7'G11 11.252 50 ND 4.4 ND
R4CP7'G12 4.691 50 ND 10.7 ND
R4CP9'B3 10.195 50 ND 4.9 ND
R4CP9'B4 16.992 50 ND 2.9 ND
R4CP9'C5 10.589 50 ND 4.7 ND
R4CP9'C6 18.866 50 ND 2.7 ND
R4CP9'C7 17.931 50 ND 2.8 ND
R4CP12CA6 10.166 20.156 ND 2.0 ND
R4CP12CA8 13.617 50 ND 3.7 ND
R4CP12CC3 11.295 50 ND 4.4 ND
R4CP12CC4 15.484 50 ND 3.2 ND
R4CP12CC5 7.793 50 ND 6.4 ND
R4CP12CC6 10.179 22.148 ND 2.2 ND
R4CP12CC7 18.301 50 ND 2.7 ND
R4CP12CD6 15.184 12.74 ND 0.8 ND
R4CP12CD7 20 21.936 ND 1.1 ND
R4CP12CE6 21.713 50 ND 2.3 ND
R4CP12CD6 11.138 50 ND 4.5 ND
R4CP12CG7 18.504 50 ND 2.7 ND
FRCP13CF7 17.451 50 ND 2.9 ND
R4CP13CF9 18.119 50 ND 2.8 ND
R4CP13CF12 7.112 50 ND 7.0 ND
R4CP13CG2 13.92 50 ND 3.6 ND
R4CP13CG3 4.178 50 ND 12.0 ND
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1H NMR spectrum of aplysulphurin (2.8), 500 MHz in CDCl3 
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1H NMR spectrum of membranolide A (2.10), 500 MHz in CDCl3 
 
1H NMR spectrum of membranolide B (2.11), 500 MHz in CDCl3 
O
O
CO2Me
O
H
O
O
OMe
!! 103!
 
1H NMR spectrum of membranolide C (2.12), 500 MHz in CDCl3 
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1H NMR spectrum of membranolide E (2.19), 500 MHz in CDCl3 
 
1H NMR spectrum of membranolide F (2.20), 500 MHz in CDCl3 
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1H NMR spectrum of membranolide G (2.21), 500 MHz in CDCl3 
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1H NMR spectrum of alternariol (3.16), d6-DMSO at 500 MHz 
 
1H NMR spectrum of alternariol methyl ether (3.17), d6-DMSO at 500 MHz 
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1H NMR spectrum of altenuene (3.18), CDCl3 at 500 MHz 
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ROESY NMR spectrum of altenuene (3.18), CDCl3 at 500 MHz 
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1H NMR spectrum of ascospiroketal A (3.19), CDCl3 at 500 MHz 
 
1H NMR spectrum of bipolarolide A (3.20), CDCl3 at 500 MHz 
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13C NMR spectrum of bipolarolide A (3.20), CDCl3 at 150 MHz 
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gCOSY NMR spectrum of bipolarolide A (3.20), CDCl3 at 600 MHz 
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gHSQCAD NMR spectrum of bipolarolide A (3.20), CDCl3 at 600 MHz 
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gHMBCAD NMR spectrum of bipolarolide A (3.20), CDCl3 at 600 MHz 
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1D NOE NMR spectrum (irradiation of 6.11 ppm) of bipolarolide A (3.20), CDCl3  
 
 
 
(+) HRESIMS of bipolarolide A (3.20) 
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1H NMR spectrum of bipolarolide B (3.21), CDCl3 at 600 MHz 
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gCOSY NMR spectrum of bipolarolide B (3.21), CDCl3 at 600 MHz 
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gHSQCAD NMR spectrum of bipolarolide B (3.21), CDCl3 at 600 MHz 
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gHMBCAD NMR spectrum of bipolarolide B (3.21), CDCl3 at 600 MHz 
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1H NMR spectrum of bipolarolide C (3.22), CD3OD at 600 MHz 
 
1H NMR spectrum of bipolarolide C (3.22), CD3OD at 150 MHz 
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gCOSY NMR spectrum of bipolarolide C (3.22), CD3OD at 600 MHz 
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gHSQCAD NMR spectrum of bipolarolide C (3.22), CD3OD at 600 MHz 
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gHMBCAD NMR spectrum of bipolarolide C (3.22), CD3OD at 600 MHz 
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1H NMR spectrum of malformin A1 (3.23), d6-DMSO at 500 MHz 
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TOCSY NMR spectrum of malformin A1 (3.23), d6-DMSO at 600 MHz 
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NOESY NMR spectrum of malformin A1 (3.23), d6-DMSO at 600 MHz 
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1H 
NMR spectrum of malformin B4 (3.24), d6-DMSO at 500 MHz 
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TOCSY NMR spectrum of malformin B4 (3.24), d6-DMSO at 600 MHz 
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NOESY NMR spectrum of malformin B4 (3.24), d6-DMSO at 600 MHz 
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1H NMR spectrum of malformin D (3.25), d6-DMSO at 500 MHz 
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gCOSY NMR spectrum of malformin D (3.25), d6-DMSO at 600 MHz 
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TOCSY NMR spectrum of malformin D (3.25), d6-DMSO at 600 MHz 
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gHMBCAD NMR spectrum of malformin D (3.25), d6-DMSO at 600 MHz 
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NOESY NMR spectrum of malformin D (3.25), d6-DMSO at 600 MHz 
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HRESIMS of malformin D (3.25) 
